0001493152-23-012545.txt : 20230417 0001493152-23-012545.hdr.sgml : 20230417 20230417161821 ACCESSION NUMBER: 0001493152-23-012545 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 45 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230417 DATE AS OF CHANGE: 20230417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TenX Keane Acquisition CENTRAL INDEX KEY: 0001851484 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41534 FILM NUMBER: 23824183 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVE, STREET 2: SUITE 2446 CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (347) 627-0058 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVE, STREET 2: SUITE 2446 CITY: NEW YORK STATE: NY ZIP: 10017 10-K 1 form10-k.htm
0001851484 false FY 0001851484 2022-01-01 2022-12-31 0001851484 TENKU:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightEntitlingHolderToReceiveTwotenthsOfOrdinaryShareMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001851484 TENKU:RightsEachRightEntitlingHolderToReceiveTwotenthsOfOneOrdinaryShareMember 2022-01-01 2022-12-31 0001851484 2022-06-30 0001851484 2023-04-17 0001851484 2022-12-31 0001851484 2021-12-31 0001851484 2021-03-01 2021-12-31 0001851484 us-gaap:CommonStockMember 2021-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001851484 TENKU:ShareholderReceivableMember 2021-12-31 0001851484 us-gaap:RetainedEarningsMember 2021-12-31 0001851484 us-gaap:CommonStockMember 2021-02-28 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001851484 TENKU:ShareholderReceivableMember 2021-02-28 0001851484 us-gaap:RetainedEarningsMember 2021-02-28 0001851484 2021-02-28 0001851484 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001851484 TENKU:ShareholderReceivableMember 2022-01-01 2022-12-31 0001851484 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001851484 us-gaap:CommonStockMember 2021-03-01 2021-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-12-31 0001851484 TENKU:ShareholderReceivableMember 2021-03-01 2021-12-31 0001851484 us-gaap:RetainedEarningsMember 2021-03-01 2021-12-31 0001851484 us-gaap:CommonStockMember 2022-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001851484 TENKU:ShareholderReceivableMember 2022-12-31 0001851484 us-gaap:RetainedEarningsMember 2022-12-31 0001851484 us-gaap:IPOMember 2022-10-17 2022-10-18 0001851484 us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2022-10-17 2022-10-18 0001851484 us-gaap:IPOMember us-gaap:CommonStockMember 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember TENKU:SponsorMember 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember TENKU:SponsorMember 2022-10-18 0001851484 us-gaap:IPOMember TENKU:UnderwriterMember 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember 2022-10-17 2022-10-18 0001851484 us-gaap:IPOMember 2022-10-18 0001851484 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember 2022-10-18 0001851484 TENKU:PublicShareholdersMember 2022-10-18 0001851484 srt:MinimumMember 2022-10-18 0001851484 srt:MaximumMember 2022-10-18 0001851484 TENKU:SponsorMember us-gaap:IPOMember 2022-10-18 0001851484 TENKU:SponsorMember 2022-10-18 0001851484 TENKU:SponsorMember srt:MaximumMember 2022-10-18 0001851484 us-gaap:IPOMember 2022-12-31 0001851484 us-gaap:IPOMember 2021-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2022-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2021-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesNotSubjectToRedemptionMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2021-01-01 2021-12-31 0001851484 us-gaap:IPOMember 2022-01-01 2022-12-31 0001851484 us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2022-01-01 2022-12-31 0001851484 us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2022-12-31 0001851484 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember 2021-03-23 2021-03-24 0001851484 TENKU:SponsorMember TENKU:ToBePaidLaterMember 2021-03-23 2021-03-24 0001851484 us-gaap:CommonClassAMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonClassAMember 2021-12-20 0001851484 us-gaap:CommonClassBMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2021-12-20 0001851484 us-gaap:CommonStockMember TENKU:SponsorMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember TENKU:SponsorMember 2021-12-20 0001851484 TENKU:UnderwriterMember srt:MaximumMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2022-11-27 2022-11-28 0001851484 2021-12-20 0001851484 TENKU:UnsecuredPromissoryNoteMember TENKU:SponsorMember srt:MaximumMember 2021-03-17 0001851484 TENKU:SponsorMember 2022-12-31 0001851484 TENKU:SponsorMember 2021-12-31 0001851484 TENKU:SponsorMember 2022-01-01 2022-12-31 0001851484 TENKU:WorkingCapitalLoanMember TENKU:SponsorMember srt:MaximumMember 2022-01-01 2022-12-31 0001851484 us-gaap:IPOMember TENKU:UnderwritersMember 2022-10-17 2022-10-18 0001851484 us-gaap:OverAllotmentOptionMember TENKU:UnderwritersMember 2022-11-27 2022-11-28 0001851484 us-gaap:IPOMember TENKU:UnderwritersMember 2022-10-18 0001851484 TENKU:UnderwritersMember 2022-10-17 2022-10-18 0001851484 us-gaap:OverAllotmentOptionMember TENKU:UnderwritersMember 2022-10-17 2022-10-18 0001851484 us-gaap:CommonStockMember srt:MaximumMember us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2022-01-01 2022-12-31 0001851484 us-gaap:CommonStockMember srt:MaximumMember us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2021-03-01 2021-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:IPOMember 2021-03-01 2021-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2021-03-01 2021-12-31 0001851484 us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember TENKU:UnderwriterMember 2022-10-17 2022-10-18 0001851484 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001851484 us-gaap:FairValueInputsLevel1Member 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number 001-41534

 

TenX Keane Acquisition

(Exact name of registrant as specified in its charter)

 

Cayman Islands   N/A

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

420 Lexington Avenue, Suite 2446

New York, NY 10170

(Address of principal executive offices and zip code)

 

(347) 627-0058

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)  

Name of each exchange on which registered

Units, each consisting of one ordinary share, $0.0001 par value, and one right entitling the holder to receive two-tenths of an ordinary share   TENKU   The Nasdaq Stock Market LLC
Ordinary shares, par value $0.0001 per share   TENK   The Nasdaq Stock Market LLC
Rights, each right entitling the holder to receive two-tenths of one ordinary share   TENKR   The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None.

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐ No

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

 

As of June 30, 2022, the aggregate market value of the Registrant’s ordinary shares held by non-affiliates of the Registrant was $0. The Registrant’s ordinary shares were not separately traded in the open market as of June 30, 2022.

 

As of April 17, 2023, there were 8,941,000 ordinary shares, par value $0.0001 per share, issued and outstanding.

 

 

 

 

 

 

TENX KEANE ACQUISITION

TABLE OF CONTENTS

 

PART I    
Item 1. Business 4
Item 1A. Risk Factors 13
Item 1B. Unresolved Staff Comments 13
Item 2. Properties 13
Item 3. Legal Proceedings 13
Item 4. Mine Safety Disclosures 13
PART II    
Item 5. Market for Registrant’s Common Equity, Related Shareholders Matters and Issuer Purchases of Equity Securities 13
Item 6. Reserved 14
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 14
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 19
Item 8. Financial Statements and Supplementary Data 19
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 19
Item 9A. Controls and Procedures 19
Item 9B. Other Information 20
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 20
PART III    
Item 10. Directors, Executive Officers and Corporate Governance 21
Item 11. Executive Compensation 28
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters 28
Item 13. Certain Relationships and Related Transactions, and Director Independence 29
Item 14. Principal Accounting Fees and Services 33
PART IV    
Item 15. Exhibits, Financial Statement Schedules 33
Item 16. Form 10-K Summary 35

 

2

 

 

CERTAIN TERMS

 

References to the “Company,” “our Company,” “our,” “us” or “we” refer to TenX Keane Acquisition, a blank check company incorporated on March 1, 2021 as a Cayman Islands exempted corporation and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Annual Report on Form 10-K as our “initial business combination.” References to our “Sponsor” refer to 10XYZ Holdings LP, a Delaware limited partnership. References to “equity-linked securities” are to any securities of the Company which are convertible into, or exchangeable or exercisable for, equity securities of the Company, including any securities issued by the Company which are pledged to secure any obligation of any holder to purchase equity securities of the Company. References to the “SEC” are to the U.S. Securities and Exchange Commission. References to our “initial public offering” or “IPO” refer to our initial public offering, which closed on October 18, 2022 (the “Closing Date”). References to “Public Shares” are to shares of our ordinary shares sold as part of the units in our initial public offering. References to “public shareholders” are to the holders of our Public Shares.

 

SPECIAL NOTE REGARDING FORWARD LOOKING STATEMENTS

 

Certain statements in this Annual Report on Form 10-K (this “Report” or “Annual Report”) may constitute “forward looking statements” for purposes of the federal securities laws. Our forward looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future and the statements under “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our financial position, business strategy and the plans and objectives of management for future operations. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward looking statements, but the absence of these words does not mean that a statement is not forward looking. Forward looking statements in this Annual Report on Form 10-K may include, for example, statements about:

 

  our ability to select an appropriate target business or businesses;
     
  our ability to complete our initial business combination;
     
  our expectations around the performance of the prospective target business or businesses;
     
  our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
     
  our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
     
  our potential ability to obtain additional financing to complete our initial business combination;
     
  our pool of prospective target businesses;
     
  the ability of our officers and directors to generate a number of potential acquisition opportunities;
     
  our public securities’ potential liquidity and trading;
     
  the lack of a market for our securities;
     
  the use of proceeds not held in the trust account described below or available to us from interest income on the trust account balance;
     
  the trust account not being subject to claims of third parties;
     
  our financial performance; or
     
  the other risk and uncertainties discussed in “Item 1A. Risk Factors,” elsewhere in this Annual Report on Form 10-K and in our other filings with the SEC.

 

The forward looking statements contained in this Annual Report on Form 10-K are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward looking statements. These risks and uncertainties include, but are not limited to, those factors described under “Part I, Item 1A. Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward looking statements. We undertake no obligation to update or revise any forward looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

3

 

 

PART I

 

Item 1. Business Overview.

 

We are a Cayman Islands company incorporated on March 1, 2021 as an exempted company with limited liability. We were formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular industry or geographic location but will initially focus in Asia. Despite our Chief Executive Officer and Chairman either being currently located in or having significant ties to the People’s Republic of China (“PRC” or “China”), for the purposes of consummating an initial business combination, we shall not undertake our initial business combination with any entity that conducts a majority of its business or is headquartered in China (including Hong Kong and Macau).

 

We do not have any specific business combination under consideration and we have not (nor has anyone on our behalf), directly or indirectly, contacted any prospective target business or had any substantive discussions, formal or otherwise, with respect to such a transaction. We intend to utilize cash derived from the proceeds of our initial public offering (the “IPO”), our securities, debt or a combination of cash, securities and debt, in effecting a business combination.

 

Initial Public Offering and Private Placement

 

In March 2021, we issued an aggregate of 1,437,500 founder shares to our Sponsor for an aggregate purchase price of $25,000, or approximately $0.017 per share. On December 20, 2021, the Board of Directors of the Company and our Sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:

 

  (a) Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each;
     
  (b) Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each; and
     
  (c) Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.

 

On December 20, 2021, the Company issued an additional 287,500 Ordinary Shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of 1,725,000 Ordinary Shares (the “Founder Shares”). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include an aggregate of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. With the consummation of the IPO (including partial exercise by the underwriter of its over-allotment option), 75,000 Founder Shares were forfeited, resulting in our Sponsor holding an aggregate of 1,650,000 Founder Shares.

 

On October 18, 2022, the Company consummated its IPO of 6,600,000 units (the “Units”), including 600,000 additional Units issued pursuant to the partial exercise by the underwriter of its over-allotment option. Each Unit consists of one ordinary share, par value $0.0001 per share, of the Company (the “Ordinary Shares”) and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination (the “Rights”). The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $66,000,000.

 

Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 394,000 Units (the “Placement Units”), each Placement Unit consisting of one Ordinary Share and one right, to 10XYZ Holdings LP (the “Sponsor”) at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000. The issuance of the Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

4

 

 

A total of $67,320,000 of the net proceeds from the IPO and the Private Placement were placed in a U.S.-based trust account established for the benefit of the Company’s public shareholders and maintained by American Stock Transfer & Trust Company, acting as trustee.

 

Our management has broad discretion with respect to the specific application of the proceeds of the IPO and the Private Placement that are held out of the trust account, although substantially all the net proceeds are intended to be applied generally towards consummating a business combination and working capital.

 

Since our IPO, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. We presently have no revenue and have had losses since inception from incurring formation and operating costs. We have relied upon the sale of our securities and loans from the Sponsor and other parties to fund our operations.

 

On December 6, 2022, we announced that holders of the Company’s Units sold in the IPO may elect to separately trade the Ordinary Shares and Rights included in the Units, commencing on or about December 8, 2022. The Ordinary Shares and Rights are trading on the Nasdaq Global Market (“Nasdaq”) under the symbols “TENK,” and “TENKR,” respectively. Units not separated will continue to trade on Nasdaq under the symbol “TENKU”. Holders of Units will need to have their brokers contact the Company’s transfer agent, American Stock Transfer & Trust Company, in order to separate the holders’ Units into Ordinary Shares and Rights.

 

COMPETITIVE ADVANTAGES

 

Leadership of an Experienced Management Team and Board of Directors

 

Our management team is led by our Chief Executive Officer, Executive Director and Chairman of our Board of Directors, Mr. Xiaofeng Yuan, our Chief Financial Officer and Executive Director, Mr. Taylor Zhang, and our Independent Directors, Ms. Cathy Jiang, Mr. Joel Mayersohn and Mr. Brian Hartzband.

 

Mr. Xiaofeng Yuan has served as our Executive Director and Chairman since March 2021, and our Chief Executive Officer since July 2021. Mr. Yuan founded 38Fule Group and served as the Chairman of Xianyang 38Fule from 1992 to 1998. Mr. Yuan also serves as the Chairman of Shaanxi 38Fule Technology Company, a developer, manufacturer, and distributor of health and personal care products in China, since 1999. Mr. Yuan founded 38Fule in 1992 and led the company to become one of the top 100 healthcare companies in China and has personally become an influential leader in the healthcare industry as well. Mr. Yuan and his team have always been devoted to women’s healthcare and wellbeing. “38Fule” has received several awards under Mr. Yuan’s leadership, including “National Brand”, “Women’s Choice Brand” and “Shaanxi’s Trademark”. Shaanxi 38Fule Technology Group received the only direct selling license in Shaanxi Province in 2016. In addition, Mr. Yuan also serves as the Deputy Chairman of China Reproductive Health Association, the Managing Director of China Youth Volunteer Organization, Adjunct Professor at Xi’an Jiaotong University as well as Visiting Professor at Xi’an Polytechnic University. Mr. Yuan has won several awards in his career, including “Top Ten Outstanding Youth in Xiangyang”, “Top Ten Outstanding Youth in Shaanxi”, “Top Ten Outstanding Entrepreneurs in Shaanxi”, “Expert with Outstanding Contribution in Shaanxi”, “Winner of China Science and Entrepreneur Award” and “National Outstanding Entrepreneur”.

 

Mr. Taylor Zhang has served as our Chief Financial Officer and Executive Director since March 2021. Mr. Zhang served as our Chief Executive Officer from March 2021 to July 2021. From May 2009 to December 2021, Mr. Zhang served as Chief Financial Officer and executive director of the China XD Plastics Company Limited, where he oversaw CXDC’s major financial and capital market matters, including Nasdaq listing, direct equity financing from world class institutional investors and a global bond offering. During his tenure at CXDC, its revenue grew at CAGR of 56% and exceeded US$1 billion in 6 years after listing on Nasdaq. From May 2008 to March 2009, Mr. Zhang served as Chief Financial Officer of Advanced Battery Technologies, Inc. From 2007 to 2008, he served as the Executive Vice President of Finance of China Natural Gas, Inc. From 2005 to 2007, Mr. Zhang worked as a research analyst in New York Private Equity. From 2000 to 2002, he was employed as Finance Manager by Datong Thermal Power Limited. Mr. Zhang contributes to our Board of Directors with extensive experience in finance and operations.

 

5

 

 

Ms. Cathy Jiang, our director, is an experienced professional in asset management and banking industries. Ms. Jiang serves as the Managing Director at Alpha Square Group, a family office in New York City. Her primary responsibility includes asset allocation, fund manager selection, and new investment initiatives. From 2017 to 2020, Ms. Jiang served as the Associate Managing Director, Greater China at Federated Hermes (NYSE: FHI), one of the largest asset management companies in the U.S. with $575.9 billion asset under management as of the end of 2020, where she focused on the company’s expansion in Asia and particularly in Greater China. Previously, she worked for Agricultural Bank of China and Bank of China in institutional business development roles covering both Asian and U.S. institutional investors.

 

Mr. Joel Mayersohn, our director, is a member at Dickinson Wright, where he specializes in corporate, securities and business law. He advises a diversified client base in private placements, public offerings, mergers and acquisitions, financing transactions and general securities law matters. He also has experience in venture capital, bridge loans and pipe financings. He is a member of the Florida and New York Bars and received his J.D. and B.A from The State University of New York at Buffalo.

 

Mr. Brian Hartzband, our director, is an experienced professional in business development and finance industry. Mr. Hartzband is a business development executive with large corporate and start-up experience. He co-founded Handcrafted 4 Home in June 2017, which is a home decor brand, specializing in handcrafted home storage products. Under his leadership, Mr. Hartzband grew the company to one of the top sellers by volume of home organization products on Wayfair.com and expanded to other large retail outlets, such as Walmart and Home Depot. Prior to founding Handcrafted 4 Home, Brian spent over 10 years in Wall Street and worked in finance for some of the largest financial institutions of the world. From January 2014 to June 2016, Mr. Hartzband worked as a Financial Advisor at Merrill Lynch, primarily responsible for managing public company executives’ stock plans and personal wealth investment strategies. From February 2008 to January 2014, Mr. Hartzband worked as a Senior Investment Associate at UBS Financial Services, where his team’s assets grew to over $125 million by developing relationships with C-Suite executives of major public companies along with international clients in China. From 2007 to March 2008 Mr. Hartzband started out at Bear Stearns (acquired by J.P. Morgan as a Marketing Assistant, primarily responsible for building and growing relationships with ultra-high net worth individuals, C-Suite executives at public companies.

 

Established Deal Sourcing Network

 

We believe our management team’s strong track record will provide us with access to high quality companies. In addition, we believe we, through our management team, have contacts and sources from which to generate acquisition opportunities and possibly seek complementary follow-on business arrangements. These contacts and sources include those in government, private and public companies, private equity and venture capital funds, investment bankers, attorneys and accountants.

 

Status as a Publicly Listed Acquisition Company

 

We believe our structure will make us an attractive business combination partner to prospective target businesses. As a publicly listed company, we will offer a target business an alternative to the traditional initial public offering process. We believe that some target businesses will favor this alternative, which we believe is less expensive, while offering greater certainty of execution, than the traditional initial public offering process. During an initial public offering, there are typically underwriting fees and marketing expenses, which would be costlier than a business combination with us. Furthermore, once a proposed business combination is approved by our shareholders (if applicable) and the transaction is consummated, the target business will have effectively become public, whereas an initial public offering is always subject to the underwriter’s ability to complete the offering, as well as general market conditions that could prevent the offering from occurring. Once public, we believe the target business would have greater access to capital and additional means of creating management incentives that are better aligned with shareholders’ interests than it would as a private company. It can offer further benefits by augmenting a company’s profile among potential new customers and vendors and aid in attracting talented management staffs.

 

6

 

 

With respect to the foregoing examples and descriptions, past performance by our management team is not a guarantee either (i) of success with respect to any business combination we may consummate or (ii) that we will be able to identify a suitable candidate for our initial business combination. Potential investors should not rely upon the historical record of our management as indicative of future performance.

 

BUSINESS STRATEGIES

 

We will seek to capitalize on the strength of our management team. Our team consists of experienced financial services, accounting and legal professionals and senior operating executives of companies operating in multiple jurisdiction. Collectively, our officers and directors have decades of experience in mergers and acquisitions and operating companies. We believe we will benefit from their accomplishments, and specifically, their current activities, in identifying attractive acquisition opportunities. However, there is no assurance that we will complete a business combination. Our officers and directors have no prior experience consummating a business combination for a “blank check” company. We believe that we will add value to these businesses primarily by providing them with access to the U.S. capital markets.

 

There is no restriction in the geographic location of targets we can pursue, although we intend to initially prioritize Asia, excluding companies located or operating in mainland China, Hong Kong or Macau. In particular, we intend to focus our search for an initial business combination on private companies in Asia, excluding companies located or operating in mainland China, Hong Kong or Macau, that have compelling economics and clear paths to positive operating cash flow, significant assets, and successful management teams that are seeking access to the U.S. public capital markets. We will primarily seek to acquire one or more businesses with a total enterprise value of between $200,000,000 and $600,000,000.

 

As an emerging market, Asia has experienced remarkable growth. The Asian economy experienced sustained expansion in recent years. We believe that Asia is entering a new era of economic growth, which we expect will result in attractive initial business combination opportunities for us. We believe the growth will primarily be driven by private sector expansion, technological innovation, increasing consumption by the middle class, structural economic and policy reforms and demographic changes in Asia.

 

The development of private equity and venture capital activities in Asia also provides us opportunities. According to the Asia-Pacific Private Equity Report 2020 issued by Bain & Company, Asia-Pacific now represents a quarter of the global PE market. According to the Asia-Pacific Private Equity Report 2020, exit value in 2019 saw a drop by 43% from 2018. With exits on hold, the value of companies held in PE portfolios, or unrealized value, reached a new high of $806 billion in June 2019, up 32% from a year earlier. Uncertain times and challenges faced by fund managers create opportunities for those who are well-prepared, which positions us as a natural exit alternative and creates opportunities for us to identify targets for our initial business combination.

 

ACQUISITION CRITERIA

 

Our management team intends to focus on creating shareholder value by leveraging its experience in the management, operation and financing of businesses to improve the efficiency of operations while implementing strategies to scale revenue organically and/or through acquisitions. We have identified the following general criteria and guidelines, which we believe are important in evaluating prospective target businesses. While we intend to use these criteria and guidelines in evaluating prospective businesses, we may deviate from these criteria and guidelines should we see justification to do so.

 

7

 

 

  Strong management team that can create significant value for target business. We will seek to identify companies with strong and experienced management teams that will complement the operating and investment abilities of our management team. We believe we can provide a platform for the existing management team to leverage the experience of our management team. We also believe that the operating expertise of our management team is well suited to complement the target’s management team.

 

  Revenue and Earnings Growth Potential. We will seek to acquire one or more businesses that have the potential for significant revenue and earnings growth through a combination of both existing and new product development, increased production capacity, expense reduction and synergistic follow-on acquisitions resulting in increased operating leverage.
     
  Potential for Strong Free Cash Flow Generation. We will seek to acquire one or more businesses that have the potential to generate strong, stable and increasing free cash flow, particularly businesses with predictable revenue streams and definable low working capital and capital expenditure requirements. We may also seek to prudently leverage this cash flow in order to enhance shareholder value.
     
  Benefit from Being a Public Company. We intend to only acquire a business or businesses that will benefit from being publicly traded and which can effectively utilize access to broader sources of capital and a public profile that are associated with being a publicly traded company.

 

This criteria does not intend to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as other considerations, factors and criteria that our Sponsor and management team may deem relevant. In the event that we decide to enter into an initial business combination with a target business that does not meet the above criteria and guidelines, we will disclose that the target business does not meet the above criteria in our shareholder communications related to our initial business combination, which would be in the form of proxy solicitation or tender offer materials, as applicable, that we would file with the U.S. Securities and Exchange Commission, or the SEC.

 

Initial Business Combination

 

Nasdaq rules require that our initial business combination must be with one or more target businesses that together have an aggregate fair market value equal to at least 80% of the balance in the trust account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of our signing a definitive agreement in connection with our initial business combination. If our Board of Directors is not able to independently determine the fair market value of the target business or businesses, we will obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm. We do not intend to purchase multiple businesses in unrelated industries in conjunction with our initial business combination.

 

We will have until 9 months from the closing of our IPO to consummate an initial business combination (the “Combination Period”). However, if we anticipate that we may not be able to consummate our initial business combination within 9 months, we may extend the Combination Period up to three times, each by an additional three months (for a total of up to 18 months to complete a business combination) without submitting such proposed extensions to our shareholders for approval or offering our public shareholders redemption rights in connection therewith. Pursuant to the terms of our amended and restated memorandum and articles of association and the trust agreement entered into between us and American Stock Transfer & Trust Company on October 13, 2022, in order to extend the time available for us to consummate our initial business combination, our Sponsor or its affiliates or designees, upon ten days advance notice prior to the applicable deadline, must deposit into the trust account $660,000 ($0.10 per share) on or prior to the date of the applicable deadline, for each three month extension (or up to an aggregate of $1,980,000, or $0.30 per share, if we extend for the full nine months). Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of our initial business combination. If we complete our initial business combination, we would repay such loaned amounts out of the proceeds of the trust account released to us. If we do not complete a business combination, we will not repay such loans. Furthermore, the letter agreement with our initial shareholders contains a provision pursuant to which our Sponsor has agreed to waive its right to be repaid for such loans out of the funds held in the trust account in the event that we do not complete a business combination. Our Sponsor and its affiliates or designees are not obligated to fund the trust account to extend the time for us to complete our initial business combination. Up to $1,500,000 of the loans made by our Sponsor, our officers and directors, or our or their affiliates to us prior to or in connection with our initial business combination (including loans made to extend our time period for consummating a business combination) may be convertible into Units at a price of $10.00 per Unit at the option of the lender.

 

8

 

 

If we are unable to consummate an initial business combination within such time period, we will, as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including any interest earned on the funds held in the trust account (net of interest that may be used by us to pay our taxes payable and for dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law and as further described herein, and then seek to dissolve and liquidate. We expect the pro rata redemption price to be approximately $10.20 per public share (subject to increase of up to an additional $0.30 per share in the event that our Sponsor elects to extend the period of time to consummate a business combination by the full nine months), without taking into account any interest earned on such funds. However, we cannot assure you that we will in fact be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of our public shareholders.

 

We anticipate structuring our initial business combination so that the post-transaction company in which our public shareholders own shares will own or acquire 100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination such that the post-transaction company owns or acquires less than 100% of such interests or assets of the target business in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended, or the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we would acquire a 100% controlling interest in the target. However, as a result of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction company, the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% of net assets test. If our initial business combination involves more than one target business, the 80% of net assets test will be based on the aggregate value of all of the target businesses.

 

Permission Required from the Chinese Authorities for a Business Combination

 

Although our offices are located in United States, a majority of our directors and officers have significant ties to China. As a result, our directors and officers who have significant ties to China may be subject to certain risks relating to regulatory oversight by the PRC government. In particular, changes in the policies, regulations, rules, and the enforcement of laws of the PRC government may be adopted quickly with little advance notice. The Chinese government may also intervene or influence our search for a target business or the completion of an initial business combination at any time through our directors and officers who have significant ties to China. This could significantly and negatively impact our search for a target business and/or the value of the securities.

 

9

 

 

As a Cayman Islands company with no operations or subsidiaries in China and expected to conduct a target search outside of China, we are not required to obtain permission from any Chinese authorities to operate, nor have we been contacted by any Chinese authorities in connection with our operations, and we do not expect that permission will be required from the Chinese authorities in the future in connection with our business combination since we will not undertake our initial business combination with any entity that is based in, located in or with its principal business operations in China (including Hong Kong and Macau).

 

Implication of the Holding Foreign Companies Accountable Act

 

The Holding Foreign Companies Accountable Act, or the HFCAA, was enacted on December 18, 2020. The HFCAA states that if the SEC determines that an issuer’s audit reports issued by a registered public accounting firm have not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit such issuer’s securities from being traded on a national securities exchange or in the over-the-counter trading market in the United States. On December 29, 2022, the Accelerating Holding Foreign Companies Accountable Act (“AHFCAA”) was enacted, which amends the HFCAA and requires the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three consecutive years.

 

Recent PCAOB Developments

 

Future developments in U.S. laws may restrict our ability or willingness to complete certain business combinations with companies. For instance, the enacted HFCAA would restrict our ability to consummate a business combination with a target business unless that business met certain standards of the PCAOB and would require delisting of a company from U.S. national securities exchanges if the PCAOB is unable to inspect its public accounting firm for three consecutive years. The HFCAA also requires public companies to disclose, among other things, whether they are owned or controlled by a foreign government. We may not be able to consummate a business combination with a favored target business due to these laws. Furthermore, on June 22, 2021, the U.S. Senate passed the AHFCAA, which, if signed into law, would amend the HFCAA and require the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead of three consecutive years.

 

The documentation we may be required to submit to the SEC proving certain beneficial ownership requirements and establishing that we are not owned or controlled by a foreign government in the event that we use a foreign public accounting firm not subject to inspection by the PCAOB or where the PCAOB is unable to inspect or investigate our accounting practices or financial statements because of a position taken by an authority in the foreign jurisdiction could be onerous and time consuming to prepare. The HFCAA mandates the SEC to identify issuers of SEC-registered securities whose audited financial reports are prepared by an accounting firm that the PCAOB is unable to inspect due to restrictions imposed by an authority in the foreign jurisdiction where the audits are performed. If such identified issuer’s auditor cannot be inspected by the PCAOB for three consecutive years, the trading of such issuer’s securities on any U.S. national securities exchanges, as well as any over-the-counter trading in the U.S., will be prohibited.

 

On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCAA. An identified issuer will be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to be subsequently established by the SEC.

 

10

 

 

On November 5, 2021, the SEC approved the PCAOB’s Rule 6100, Board Determinations Under the Holding Foreign Companies Accountable Act. Rule 6100 provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether it is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction.

 

On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the Holding Foreign Companies Accountable Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in foreign jurisdictions.

 

On December 16, 2021, the PCAOB issued a Determination Report which found that the PCAOB is unable to inspect or investigate certain registered public accounting firms headquartered in: (i) mainland China, and (ii) Hong Kong. In addition, the PCAOB’s report identified the specific registered public accounting firms that are subject to these determinations. On August 26, 2022, the PCAOB signed a Statement of Protocol with the China Securities Regulatory Commission and the Ministry of Finance of the PRC (“SOP”), taking the first step toward opening access for the PCAOB to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong completely, consistent with U.S law. Pursuant to the SOP, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation and has the unfettered ability to transfer information to the SEC.

 

On December 15, 2022, the PCAOB determined that the PCAOB was able to secure complete access to inspect and investigate registered public accounting firms headquartered in mainland China and Hong Kong and voted to vacate its previous determinations to the contrary. However, should PRC authorities obstruct or otherwise fail to facilitate the PCAOB’s access in the future, the PCAOB will consider the need to issue a new determination.

 

Our auditor, Marcum LLP, headquartered in New York, NY, is an independent registered public accounting firm with the PCAOB and has been inspected by the PCAOB on a regular basis. The PCAOB currently has access to inspect the working papers of our auditor. If, for whatever reason, the PCAOB is unable to conduct inspections or full investigations of our auditor, we could be delisted or prohibited from being traded over the counter. If our securities are unable to be listed on another securities exchange by then, such delisting and prohibition would substantially impair your ability to sell or purchase our securities when you wish to do so, and the risk and uncertainty associated with potential delisting and prohibition would have a negative impact on the price of our securities. Also, such delisting and prohibition could significantly affect our ability to raise capital on acceptable terms, or at all, which would have a material adverse effect on our business, financial condition and prospects. Future developments in respect of increase U.S. regulatory access to audit information are uncertain, as the legislative developments are subject to the legislative process and the regulatory developments are subject to the rule-making process and other administrative procedures.

 

In the event that we complete a business combination with a non-U.S. company and any of the legislative actions or regulatory changes discussed above were to proceed in ways that are detrimental to a non-U.S. issuer, it could cause us to fail to be in compliance with U.S. securities laws and regulations, we could cease to be listed on a U.S. securities exchange, and U.S. trading of our shares could be prohibited. Any of these actions, or uncertainties in the market about the possibility of such actions, could adversely affect our prospects to successfully complete a business combination with a non-U.S. company, our access to the U.S. capital markets and the price of our shares.

 

11

 

 

Corporate Information

 

We are an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market for our securities and the prices of our securities may be more volatile.

 

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take advantage of the benefits of this extended transition period.

 

We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of the completion of our IPO, (b) in which we have total annual gross revenue of at least $1.07 billion, or (c) in which we are deemed to be a large accelerated filer, which means the market value of our Ordinary Shares that is held by non-affiliates exceeds $700 million as of the prior December 31, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. References herein to “emerging growth company” shall have the meaning associated with it in the JOBS Act.

 

Additionally, we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our Ordinary Shares held by non-affiliates equals or exceeds $250 million as of the end of the second fiscal quarter of such fiscal year, or (2) our annual revenues equaled or exceeded $100 million during such completed fiscal year and the market value of our Ordinary Shares held by non-affiliates equals or exceeds $700 million as of the end of the second fiscal quarter of such fiscal year.

 

Exempted companies are Cayman Islands companies wishing to conduct business outside the Cayman Islands and, as such, are exempted from complying with certain provisions of the Companies Act. As an exempted company, we have applied for and expect to receive a tax exemption undertaking from the Cayman Islands government that, in accordance with Section 6 of the Tax Concessions Act (Revised) of the Cayman Islands, for a period of 20 years from the date of the undertaking, no law which is enacted in the Cayman Islands imposing any tax to be levied on profits, income, gains or appreciations shall apply to us or our operations and, in addition, that no tax to be levied on profits, income, gains or appreciations or which is in the nature of estate duty or inheritance tax shall be payable (i) on or in respect of our shares, debentures or other obligations or (ii) by way of the withholding in whole or in part of a payment of dividend or other distribution of income or capital by us to our shareholders or a payment of principal or interest or other sums due under a debenture or other obligation of us.

 

We are a Cayman Islands exempted company incorporated on March 1, 2021. Our executive offices are located at 420 Lexington Ave Suite 2446, New York, NY 10170, and our telephone number is 347-627-0058. The cost for this space is provided to us by our Sponsor, as part of the $10,000 per month payment we make to it for office space and related services. We consider our current office space adequate for our current operations.

 

Employees

 

We currently have 2 officers. These individuals are not obligated to devote any specific number of hours to our matters but they intend to devote as much of their time as they deem necessary to our affairs until we have completed our initial business combination. The amount of time they will devote in any time period will vary based on whether a target business has been selected for our initial business combination and the stage of the initial business combination process we are in. We do not intend to have any full time employees prior to the completion of our initial business combination.

 

12

 

 

Item 1A. Risk Factors.

 

As a smaller reporting company, we are not required to include risk factors in this Annual Report.

 

Item 1B. Unresolved Staff Comments.

 

None.

 

Item 2. Properties.

 

We do not own any real estate or other physical properties materially important to our operations. We maintain our principal executive offices are located at 420 Lexington Ave Suite 2446, New York, NY 10170, and our telephone number is 347-627-0058.

 

Item 3. Legal Proceedings.

 

We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

PART II

 

Item 5. Market Information.

 

Our Units, Ordinary Shares, and Rights are each traded on The Nasdaq Global Market (“Nasdaq”) under the symbols “TENKU,” “TENK,” and “TENKR,” respectively.

 

Holders

 

As of the date hereof, we had 4 holders of record of our Units, 4 holders of record of our separately traded Ordinary Shares, and 1 holder of our separately traded Rights. The number of record holders was determined from the records of our transfer agent.

 

Dividends

 

We have not paid any cash dividends on our Ordinary Shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination will be within the discretion of our Board of Directors at such time. In addition, our Board of Directors is not currently contemplating and does not anticipate declaring any share dividends in the foreseeable future. Further, if we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.

 

Securities Authorized for Issuance Under Equity Compensation Plans

 

None.

 

13

 

 

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings

 

In March 2021, we issued an aggregate of 1,437,500 founder shares to our Sponsor for an aggregate purchase price of $25,000, or approximately $0.017 per share. On December 20, 2021, the Board of Directors of the Company and our Sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:

 

  (a) Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each;
     
  (b) Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each; and
     
  (c) Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.

 

On December 20, 2021, the Company issued an additional 287,500 Ordinary Shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of 1,725,000 Ordinary Shares (the “Founder Shares”). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include an aggregate of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. With the consummation of the IPO (including partial exercise by the underwriter of its over-allotment option), 75,000 Founder Shares were forfeited, resulting in our Sponsor holding an aggregate of 1,650,000 Founder Shares.

 

On October 18, 2022, the Company consummated its IPO of 6,600,000 Units, including 600,000 additional Units issued pursuant to the partial exercise by the underwriter of its over-allotment option. Each Unit consists of one ordinary share, par value $0.0001 per share, of the Company and one Right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $66,000,000.

 

Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement of 394,000 Units (the “Placement Units”), each Placement Unit consisting of one Ordinary Share and one Right, to the Sponsor at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000.

 

As of October 18, 2022, transaction costs amounted to $4,859,330 consisting of $1,320,000 of cash underwriting fees, non-cash underwriting fees of $2,922,480 represented by the fair value of 297,000 shares issued to the underwriter and $616,850 of other offering costs.

 

A total of $67,320,000 of the net proceeds from the IPO and the Private Placement were placed in a U.S.-based trust account established for the benefit of the Company’s public shareholders and maintained by American Stock Transfer & Trust Company, acting as trustee.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Item 6. Reserved.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “us,” “our” or “we” refer to TenX Keane Acquisition. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and related notes included herein. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

 

14

 

 

Overview

 

We were incorporated in the Cayman Islands on March 1, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

 

Results of Operations and Known Trends or Future Events

 

We have not generated any revenues to date, and we will not be generating any operating revenues until the closing and completion of our initial business combination. Our entire activity up to December 31, 2022 has been related to our formation, the Initial Public Offering and, since the closing of the Initial Public Offering, and a search for a business combination target. We have, and expect to continue to generate, non-operating income in the form of interest income and unrealized gains on investments held in the trust account. We expect to continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with the search for a business combination target.

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities since inception have been organizational activities and those necessary to prepare for the IPO. Following the IPO, we will not generate any operating revenues until after completion of our initial business combination. We will generate non-operating income in the form of interest income on cash and cash equivalents after the IPO. After the IPO, we expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as expenses as we conduct due diligence on prospective business combination candidates. We expect our expenses to increase substantially after the closing of the IPO.

 

For the year ended December 31, 2022, we had net income of $380,811, which primarily consisted of investment income on the trust assets of $493,020, partially offset by operating expenses of $138,115.

 

Liquidity, Capital Resources Going Concern

 

As of December 31, 2022 our cash was $289,175.

 

Our registration statement for the IPO (the “Registration Statement”) was declared effective on October 13, 2022. On October 18, 2022, we consummated the IPO of 6,600,000 Units, including 600,000 additional Units issued pursuant to the partial exercise by the underwriter of its over-allotment option (with respect to the common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $66,000,000.

 

Simultaneously with the consummation of the IPO and the sale of the Units, we consummated the Private Placement of 394,000 Placement Units to the Sponsor at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000.

 

Following the closing of the IPO on October 18, 2022, an amount of $67,320,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement was placed in the trust account. The funds held in the trust account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by us meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the us, until the earlier of: (i) the completion of a business combination or (ii) the distribution of the trust account.

 

We intend to use substantially all of the funds held in the trust account, including any amounts representing interest earned on the trust account, to complete our initial business combination. To the extent that our capital stock or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

 

15

 

 

As of December 31, 2022, we had available to us approximately $289,175 of proceeds held outside the trust account. We will use these funds to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete an initial business combination.

 

In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds on a non-interest bearing basis as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Other than as described above, the terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

 

We expect our primary liquidity requirements during that period to include $92,000 for legal, accounting, due diligence, travel and other expenses associated with structuring, negotiating and documenting successful business combinations as well as legal and accounting fees related to regulatory reporting requirements, and $216,800 for working capital that will be used for miscellaneous expenses and reserves. In addition, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 if we need additional capital.

 

These amounts are estimates and may differ materially from our actual expenses. In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable to such target businesses) with respect to a particular proposed initial business combination, although we do not have any current intention to do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise) could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target businesses.

 

We do not believe we will need to raise additional funds following the IPO in order to meet the expenditures required for operating our business. However, if our estimates of the costs of identifying a target business, undertaking in-depth due diligence and negotiating an initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to complete our initial business combination or because we become obligated to redeem a significant number of our Public Shares upon completion of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination. In addition, we are targeting businesses larger than we could acquire with the net proceeds of the IPO and the sale of the Private Units, and may as a result be required to seek additional financing to complete such proposed initial business combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our initial business combination. If we are unable to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following our initial business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.

 

16

 

 

There is no assurance that our plans to consummate a business combination will be successful within the combination period. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued.

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that the funds which the Company has available following the completion of the Initial Public Offering will enable it to sustain operations for a period of at least one-year from the issuance date of this financial statement. However, management has determined that the combination period is less than one year from the date of the issuance of the financial statements. There is no assurance that the Company’s plans to consummate a business combination will be successful within the combination period. The liquidation deadline before any extension is less than a year from the date of this report. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

The change in cash for the year ended December 31, 2022 was an increase of $289,175 and was comprised of cash used in operating activities of $47,968, cash used in investing activities of $67,320,000 and cash provided by financing activities of $67,657,143. The investing and financing activities related to the IPO proceeds and investing the proceeds in the trust account.

 

Contractual Obligations

 

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.

 

Our Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our Sponsor, officers or directors or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 

In addition, in order to finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. The terms of such loans by our officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our Sponsor or an affiliate of our Sponsor as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account.

 

Our Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a business combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the our initial business combination or to redeem 100% of the Public Shares if we do not complete a business combination within the Combination Period or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless we provide the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.

 

17

 

 

Our Sponsor has agreed to waive its rights to liquidating distributions from the trust account with respect to the Founder Shares it will receive if we fail to complete a business combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the trust account if we fail to complete a business combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.00).

 

The holders of the Founder Shares, Placement Units and Units that may be issued upon conversion of Working Capital Loans (and any shares of Ordinary Shares issuable upon the exercise of the Private Placement Right) will be entitled to registration rights pursuant to a registration rights agreement signed prior to or on the effective date of the IPO requiring us to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a business combination and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. We will bear the expenses incurred in connection with the filing of any such registration statements.

 

Critical Accounting Estimates

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies or estimates.

 

Deferred Offering Costs

 

Deferred offering costs consist of costs incurred in connection with preparation for the IPO. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the IPO. As of December 31, 2022 and 2021 we had deferred offering costs of $0 and $126,422, respectively.

 

Net income (loss) per share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.

 

The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.

 

18

 

 

Derivative Financial Instruments

 

We evaluate our financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk.

 

As of December 31, 2022, we were not subject to any market or interest rate risk. Following the consummation of our IPO, the net proceeds of our IPO, including amounts in the trust account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 185 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

 

Item 8. Financial Statements and Supplementary Data.

 

This information appears following Item 15 of this Form 10-K and is incorporated herein by reference.

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

None.

 

Item 9A. Controls and Procedures.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under Securities Exchange Act of 1934, as amended (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Evaluation of Disclosure Controls and Procedures

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

19

 

 

Management’s Annual Report on Internal Control over Financial Reporting

 

As required by SEC rules and regulations implementing Section 404 of the Sarbanes-Oxley Act, our management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with GAAP. Our internal control over financial reporting includes those policies and procedures that:

 

  (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company,
     
  (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and
     
  (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect errors or misstatements in our financial statements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree or compliance with the policies or procedures may deteriorate. Management assessed the effectiveness of our internal control over financial reporting at December 31, 2022. In making these assessments, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control — Integrated Framework (2013). Based on our assessments and those criteria, management determined that we maintained effective internal control over financial reporting as of December 31, 2022.

 

This Annual Report on Form 10-K does not include an attestation report of internal controls from our independent registered public accounting firm due to our status as an emerging growth company under the JOBS Act.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Item 9B. Other Information.

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

 

None.

 

20

 

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance

 

Our current officers and directors are as follows:

 

Name   Age   Title
Xiaofeng Yuan   50   Chief Executive Officer and Chairman of the Board of Directors
Taylor Zhang   42   Chief Financial Officer and Director
Cathy Jiang   32   Director
Joel Mayersohn   63   Director
Brian Hartzband   36   Director

 

Xiaofeng Yuan has served as our Executive Director and Chairman since March 2021, and our Chief Executive Officer since July 2021. Mr. Yuan founded 38Fule Group and served as the Chairman of Xianyang 38Fule from 1992 to 1998. Mr. Yuan also serves as the Chairman of Shaanxi 38Fule Technology Company, a developer, manufacturer, and distributor of health and personal care products in China, since 1999. Mr. Yuan founded 38Fule in 1992 and led the company to become one of the top 100 healthcare companies in China and himself is an influential leader in the healthcare industry as well. Mr. Yuan and his team have always been devoted to women’s healthcare and wellbeing. “38Fule” has received several awards under Mr. Yuan’s leadership, including “National Brand”, “Women’s Choice Brand” and “Shaanxi’s Trademark”. Shaanxi 38Fule Technology Group received the only direct selling license in Shaanxi Province in 2016. In addition, Mr. Yuan also serves as the Deputy Chairman of China Reproductive Health Association, the Managing Director of China Youth Volunteer Organization, Adjunct Professor at Xi’an Jiaotong University as well as Visiting Professor at Xi’an Polytechnic University. We believe that Mr. Yuan is qualified to serve on our board due to his extensive experience in management and leadership skills.

 

Taylor Zhang has served as our Chief Financial Officer and Executive Director since March 2021. Mr. Zhang served as our Chief Executive Officer from March 2021 to July 2021. From May 2009 to December 2021, Mr. Zhang served as Chief Financial Officer and executive director of the China XD Plastics Company Limited (CXDC), where he oversees CXDC’s major financial and capital market matters, including Nasdaq listing, direct equity financing from world class institutional investors and a global bond offering. During his tenure at CXDC, its revenue grew at CAGR of 56% and exceeded US$1 billion in 6 years after listing on Nasdaq. From May 2008 to March 2009, Mr. Zhang served as Chief Financial Officer of Advanced Battery Technologies, Inc. From 2007 to 2008, he served as the Executive Vice President of Finance of China Natural Gas, Inc. From 2005 to 2007, Mr. Zhang worked as a research analyst in New York Private Equity. From 2000 to 2002, he was employed as Finance Manager by Datong Thermal Power Limited. Mr. Zhang contributes to our Board of Directors with extensive experience in finance and operations. He holds an MBA from University of Florida and a Bachelor’s Degree in Mechanical and Electronic Engineering from Beijing Technology and Business University.

 

Cathy Jiang is an experienced professional in asset management and banking industries. Ms. Jiang serves as the Managing Director at Alpha Square Group, a family office in New York City. Her primary responsibility includes asset allocation, fund manager selection, and new investment initiatives. From 2017 to 2020, Ms. Jiang served as the Associate Managing Director, Greater China at Federated Hermes (NYSE: FHI), one of the largest asset management companies in the U.S. with $575.9 billion asset under management as of the end of 2020, where she focused on the company’s expansion in Asia and particularly in Greater China. Previously, she worked for Agricultural Bank of China and Bank of China in institutional business development roles covering both Asian and U.S. institutional investors. Ms. Jiang received her M.A. degree from Michigan State University. We believe that Ms. Jiang is well qualified to serve on our board due to her extensive experience in finance.

 

Joel Mayersohn is a member at Dickinson Wright, where he specializes in corporate, securities and business law. He advises a diversified client base in private placements, public offerings, mergers and acquisitions, financing transactions and general securities law matters. He also has experience in venture capital, bridge loans and pipe financings. He is a member of the Florida and New York Bars and received his J.D. and B.A from The State University of New York at Buffalo. We believe that Mr. Mayersohn is well qualified to serve on our board due to his extensive experience in corporate and finance legal matters.

 

21

 

 

Brian Hartzband is a business development executive with large corporate and start-up experience. He co-founded Handcrafted 4 Home in June 2017, which is a home decor brand, specializing in handcrafted home storage products. Under his leadership, Mr. Hartzband grew the company to one of the top sellers by volume of home organization products on Wayfair.com and expanded to other large retail outlets, such as Walmart and Home Depot. Prior to founding Handcrafted 4 Home, Brian spent over 10 years in Wall Street and worked in finance for some of the largest financial institutions of the world. From January 2014 to June 2016, Mr. Hartzband worked as a Financial Advisor at Merrill Lynch, primarily responsible for managing public company executives’ stock plans and personal wealth investment strategies. From February 2008 to January 2014, Mr. Hartzband worked as a Senior Investment Associate at UBS Financial Services, where his team’s assets grew to over $125 million by developing relationships with C-Suite executives of major public companies along with international clients in China. From 2007 to March 2008 Mr. Hartzband started out at Bear Stearns (acquired by J.P. Morgan as a Marketing Assistant, primarily responsible for building and growing relationships with ultra-high net worth individuals, C-Suite executives at public companies. Mr. Hartzband holds a B.S. in Finance from Suffolk University. We believe that Mr. Hartzband is well qualified to serve on our board due to his extensive experience in finance.

 

None of our management team has any experience with blank check companies. As such, there is no guarantee that we will be successful with respect to any business combination we may consummate or that we will be able to identify a suitable candidate for our initial business combination. As such, there is no guarantee that we will be successful with respect to any business combination we may consummate or that we will be able to identify a suitable candidate for our initial business combination.

 

Number, Terms of Office and Election of Officers and Directors

 

Our Board of Directors consists of five members. Each of our directors will hold office for a two-year term. Subject to any other special rights applicable to the shareholders, any vacancies on our Board of Directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our board or by a majority of the holders of our Ordinary Shares.

 

Our officers are elected by the Board of Directors and serve at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of a Chairman, Chief Executive Officer, President, Chief Financial Officer, Vice Presidents, Secretary, Assistant Secretaries, Treasurer and such other offices as may be determined by the Board of Directors.

 

Director Independence

 

The Nasdaq listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). Our board has determined that each of Cathy Jiang, Joel Mayersohn and Brian Hartzband is an independent director under applicable SEC and Nasdaq rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.

 

Officer and Director Compensation

 

None of our officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will pay an affiliate of our Sponsor a total of $10,000 per month for office space, administrative and support services. Our Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our Sponsor, officers, directors or our or their affiliates.

 

22

 

 

After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time such materials are distributed, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined by a compensation committee constituted solely by independent directors.

 

We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.

 

Committees of the Board of Directors

 

Our Board of Directors has two standing committees: an audit committee and a compensation committee. Each committee will operate under a charter that has been approved by our board and will have the composition and responsibilities described below. Subject to phase-in rules and a limited exception, Nasdaq rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors, and Nasdaq rules require that the compensation committee of a listed company be comprised solely of independent directors.

 

Audit Committee

 

We have established an audit committee of the Board of Directors. The members of our audit committee are Cathy Jiang, Joel Mayersohn and Brian Hartzband. Cathy Jiang will serve as chairman of the audit committee.

 

Each member of the audit committee is financially literate and our Board of Directors has determined that Cathy Jiang qualifies as an “audit committee financial expert” as defined in applicable SEC rules.

 

We have adopted an audit committee charter, which details the principal functions of the audit committee, including:

 

  the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;
     
  pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
     
  reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;
     
  setting clear hiring policies for employees or former employees of the independent auditors;
     
  setting clear policies for audit partner rotation in compliance with applicable laws and regulations;

 

23

 

 

  obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
     
  reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
     
  reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.

 

Compensation Committee

 

We have established a compensation committee of the Board of Directors. The members of our Compensation Committee are Cathy Jiang, Joel Mayersohn and Brian Hartzband. Joel Mayersohn will serve as chairman of the compensation committee. We have adopted a compensation committee charter, which details the principal functions of the compensation committee, including:

 

  reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer’s based on such evaluation;
     
  reviewing and approving the compensation of all of our other officers;
     
  reviewing our executive compensation policies and plans;
     
  implementing and administering our incentive compensation equity-based remuneration plans;
     
  assisting management in complying with our proxy statement and annual report disclosure requirements;
     
  approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;
     
  producing a report on executive compensation to be included in our annual proxy statement; and
     
  reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.

 

The charter also provides that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.

 

24

 

 

Director Nominations

 

We do not have a standing nominating committee though we intend to form a corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance with Rule 5605(e)(2) of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the Board of Directors. The Board of Directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee. In accordance with the Nasdaq rules, all such directors are independent. As there is no standing nominating committee, we do not have a nominating committee charter in place.

 

The Board of Directors will also consider director candidates recommended for nomination by our shareholders during such times as they are seeking proposed nominees to stand for election at the next annual meeting of shareholders (or, if applicable, a special meeting of shareholders). Our shareholders that wish to nominate a director for election to our Board of Directors should follow the procedures set forth in our bylaws.

 

We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for directorship, the Board of Directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.

 

Compensation Committee Interlocks and Insider Participation

 

None of our officers currently serves, and in the past year has not served, (i) as a member of the compensation committee or Board of Directors of another entity, one of whose executive officers served on our compensation committee, or (ii) as a member of the compensation committee of another entity, one of whose executive officers served on our Board of Directors.

 

Code of Ethics

 

We have adopted a Code of Ethics applicable to our directors, officers and employees. You will be able to review these documents by accessing our public filings at the SEC’s web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K.

 

Conflicts of Interest

 

Under Cayman Islands law, directors and officers owe the following fiduciary duties:

 

  duty to act bona fide in the best interests of the company;
     
  duty not to make a profit based on their positions as director (unless the company permits them to do so); and
     
  duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests.

 

In addition to the above, directors also owe to the company a duty of to act with skill and care which is not fiduciary in nature. This duty has been considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands.

 

25

 

 

As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings.

 

Each of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will provide that, subject to his or her fiduciary duties under Cayman Islands law, we renounce our interest in any corporate opportunity offered to any officer or director unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of our company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers would materially undermine our ability to complete our business combination.

 

Members of our management team may become an officer or director of another special purpose acquisition company with a class of securities registered under the Exchange Act even before we have entered into a definitive agreement regarding our initial business combination. Potential investors should also be aware of the following other potential conflicts of interest:

 

  None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.
     
  In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.
     
  Our Sponsor, officers and directors have agreed to waive their redemption rights with respect to our Founder Shares and Public Shares in connection with the consummation of our initial business combination. Additionally, our Sponsor, officers and directors have agreed to waive their redemption rights with respect to their Founder Shares if we fail to consummate our initial business combination within 9 months after the closing of our IPO (or up to 18 months from the closing of our IPO if we extend the period of time to consummate a business combination by the full amount of time). If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the Placement Units held in the trust account will be used to fund the redemption of our Public Shares, and the Rights will expire worthless. With certain limited exceptions, the Founder Shares will not be transferable, assignable or salable by our Sponsor until the earlier of (1) one year after the completion of our initial business combination and (2) the date on which we consummate a liquidation, merger, share exchange, reorganization, or other similar transaction after our initial business combination that results in all of our shareholders having the right to exchange their Ordinary Shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of our Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination, the Founder Shares will be released from the lock-up. With certain limited exceptions, the Placement Units, Private Placement Shares, Private Placement Rights and the Ordinary Shares underlying such Rights will not be transferable, assignable or salable by our Sponsor until 30 days after the completion of our initial business combination. Since our Sponsor and officers and directors may directly or indirectly own Ordinary Shares and Rights following our IPO, our officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.

 

26

 

 

  Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.

 

The conflicts described above may not be resolved in our favor.

 

Accordingly, as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. Below is a table summarizing the entities to which our officers and directors currently have fiduciary duties or contractual obligations:

 

Individual   Entity   Entity’s Business   Affiliation
Xiaofeng Yuan  

Shaanxi 38Fule Technology Company

 

Healthcare company

 

Chairman

             
Taylor Zhang   Ascendant Global Advisors, Inc   Business consulting and advisory   Managing Director
             

Cathy Jiang

  Alpha Square Group   Family office investing in growth-stage Fintech and Enterprise SaaS companies   Managing Director
             
    Guangdong-Hong Kong-Macao Greater Bay Area Youth Entrepreneurship Incubator   Hong Kong based incubator to support and fund young entrepreneurs in Greater Bay Area in China   Mentor
             

Brian Hartzband

 

Handcrafted 4 Home

  A home decor brand specializing in handcrafted home storage products  

Co-Founder

             
Joel Mayersohn   Dickinson Wright PLLC   Full-service law firm in the U.S.   Member

 

Accordingly, if any of the above officers or directors becomes aware of a business combination opportunity which is suitable for any of the above entities to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and only present it to us if such entity rejects the opportunity, subject to his or her fiduciary duties under Cayman Islands law.

 

We are not prohibited from pursuing an initial business combination with a company that is affiliated with our Sponsor, officers or directors. In the event we seek to complete our initial business combination with such a company, we, or a committee of independent directors, would obtain an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm, that such an initial business combination is fair to our Company from a financial point of view.

 

In the event that we submit our initial business combination to our public shareholders for a vote, our Sponsor, officers and directors have agreed, pursuant to the terms of a letter agreement entered into with us, to vote any Founder Shares held by them (and their permitted transferees will agree) and any Public Shares purchased during or after the IPO in favor of our initial business combination.

 

27

 

 

Limitation on Liability and Indemnification of Officers and Directors

 

Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against willful default, fraud or the consequences of committing a crime. Our amended and restated memorandum and articles of association will provide for indemnification of our officers and directors to the maximum extent permitted by law, including for any liability incurred in their capacities as such, except through their own actual fraud or willful default. We may purchase a policy of directors’ and officers’ liability insurance that insures our officers and directors against the cost of defense, settlement or payment of a judgment in some circumstances and insures us against our obligations to indemnify our officers and directors.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Item 11. Executive Compensation.

 

None of our officers or directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on Nasdaq through the earlier of consummation of our initial business combination and our liquidation, we will pay an affiliate of our Sponsor a total of $10,000 per month for office space, administrative and support services. Our Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our Sponsor, officers, directors or our or their affiliates.

 

After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other fees from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time such materials are distributed, because the directors of the post-combination business will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined by a compensation committee constituted solely by independent directors.

 

We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters.

 

The following table sets forth information regarding the beneficial ownership of our Ordinary Shares as of the date hereof by:

 

  each person known by us to be the beneficial owner of more than 5% of our outstanding Ordinary Shares;
     
  each of our officers and directors; and
     
  all of our officers and directors as a group.

 

28
 

 

Unless otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary shares beneficially owned by them.

 

The beneficial ownership of our Ordinary Shares is based on an aggregate of 8,941,000 Ordinary Shares issued and outstanding as of the date hereof.

 

Name and Address of Beneficial Owner(1)  Number
of Ordinary Shares
Beneficially
Owned(2)
   Approximate
Percentage of
Outstanding
Ordinary Shares
 
10XYZ Holdings LP (3)   2,044,000    22.9%
Xiaofeng Yuan (3)   2,044,000    22.9%
Taylor Zhang (3)   2,044,000    22.9%
Cathy Jiang        
Joel Mayersohn        
Brian Hartzband        
All executive officers and directors as a group (5 individuals)   2,044,000    22.9%
           
Hudson Bay Capital Management LP(4)   500,000    5.6%

 

(1) Unless otherwise noted, the business address of each of the following entities or individuals is 420 Lexington Ave Suite 2446, New York, NY 10170.
   
(2) Interests shown consist of Founder Shares and Private Placement Shares.
   
(3) Each of Xiaofeng Yuan, our Chief Executive Officer and Chairman of our Board of Directors and Taylor Zhang, our Chief Financial Officer, may be deemed to beneficially own shares held by our Sponsor by virtue of his control over 10XYZ Management LLC, the general partner of our Sponsor, as its managing members. Each of Mr. Yuan and Mr. Zhang disclaims beneficial ownership of our ordinary shares held by our Sponsor other than to the extent of his pecuniary interest in such shares.
   
(4) Based on a Schedule 13G filed by the reporting persons. Mr. Sander Gerber serves as the managing member of Hudson Bay Capital GP LLC, which is the general partner of Hudson Bay Capital Management LP. Mr. Gerber disclaims beneficial ownership of these securities. The address for the reporting persons is 28 Havemeyer Place, 2nd Floor, Greenwich, CT 06830.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

In March 2021, we issued an aggregate of 1,437,500 founder shares to our Sponsor for an aggregate purchase price of $25,000, or approximately $0.017 per share. On December 20, 2021, the Board of Directors of the Company and our Sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:

 

  (a) Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each;
  (b) Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each; and
  (c) Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.

 

29

 

 

On December 20, 2021, the Company issued an additional 287,500 Ordinary Shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of 1,725,000 Ordinary Shares (the “Founder Shares”). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The Founder Shares include an aggregate of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. With the consummation of the IPO (including partial exercise by the underwriter of its over-allotment option), 75,000 Founder Shares were forfeited, resulting in our Sponsor holding an aggregate of 1,650,000 Founder Shares.

 

On October 18, 2022, simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 394,000 Units (the “Placement Units”), each Placement Unit consisting of one Ordinary Share (the “Private Placement Share”) and one right (the “Private Placement Right”), to the Sponsor at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000. The Private Placement Shares and the Private Placement Rights (including the Ordinary Shares issuable upon conversion of the Private Placement Rights) may not, subject to certain limited exceptions, be transferred, assigned or sold by it until 30 days after the completion of our initial business combination. There will be no redemption rights or liquidating distributions from the trust account with respect to the Founder Shares, Private Placement Shares, or Private Placement Rights which will expire worthless if we do not consummate a business combination within the allotted 9-month period (or up to 18 months from the closing of our IPO if we extend the period of time to consummate a business combination by the full amount of time). The issuance of the Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

As more fully discussed in “Item 10. Directors, Executive Officers and Corporate Governance — Conflicts of Interest,” if any of our officers or directors becomes aware of a business combination opportunity that falls within the line of business of any entity to which he or she has then-current fiduciary or contractual obligations, he or she may be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity to us, subject to his or her fiduciary duties under Cayman Islands law. Our officers and directors currently have certain relevant fiduciary duties or contractual obligations that may take priority over their duties to us.

 

We entered into an Administrative Services Agreement with our Sponsor pursuant to which we will pay a total of $10,000 per month for office space, administrative and support services to such affiliate. Upon completion of our initial business combination or our liquidation, we will cease paying these monthly fees. Accordingly, in the event the consummation of our initial business combination takes the maximum 9 months (or up to 18 months from the closing of our IPO if we extend the period of time to consummate a business combination by the full amount of time), an affiliate of our Sponsor will be paid a total of $120,000 ($10,000 per month) for office space, administrative and support services and will be entitled to be reimbursed for any out-of-pocket expenses.

 

Our Sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our Sponsor, officers, directors or our or their affiliates and will determine which expenses and the amount of expenses that will be reimbursed. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in connection with activities on our behalf.

 

Pursuant to a promissory note, our Sponsor agreed to loan to us up to $300,000 to be used for a portion of the expenses of our IPO. As of December 31, 2022, we did not have any borrowings under the promissory note with our Sponsor.

 

30

 

 

Pursuant to our amended and restated memorandum and articles of association, we may extend the period of time to consummate a business combination up to three times, each by an additional three months (for a total of up to 18 months to complete a business combination) without submitting such proposed extensions to our shareholders for approval or offering our public shareholders redemption rights in connection therewith. In order to extend the time available for us to consummate our initial business combination, our Sponsor or its affiliates or designees, upon ten days advance notice prior to the applicable deadline, must deposit into the trust account $660,000 ($0.10 per share) on or prior to the date of the applicable deadline, for each three month extension (or up to an aggregate of $1,980,000, or $0.30 per share, if we extend for the full nine months). Any such payments would be made in the form of a loan. Any such loans will be non-interest bearing and payable upon the consummation of our initial business combination. If we complete our initial business combination, we would repay such loaned amounts out of the proceeds of the trust account released to us. If we do not complete a business combination, we will not repay such loans.

 

In addition, in order to finance transaction costs in connection with an intended initial business combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts. In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment.

 

Up to $1,500,000 of the loans made by our Sponsor, our officers and directors, or our or their affiliates to us prior to or in connection with our initial business combination may be convertible into Units, at a price of $10.00 per Unit at the option of the lender, upon consummation of our initial business combination. The Units would be identical to the Placement Units. The terms of such loans by our Sponsor, our officers and directors, or their affiliates, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans from parties other than our Sponsor, our officers and directors or an affiliate of theirs as we do not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in our trust account

 

After our initial business combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company with any and all amounts being fully disclosed to our shareholders, to the extent then known, in the tender offer or proxy solicitation materials, as applicable, furnished to our shareholders. It is unlikely the amount of such compensation will be known at the time of distribution of such tender offer materials or at the time of a shareholder meeting held to consider our initial business combination, as applicable, as it will be up to the directors of the post-combination business to determine executive and director compensation.

 

We entered into a registration rights agreement with respect to the Founder Shares, Placement Units, and Units that may be issued on conversion of working capital loans (and in each case holders of their component securities, as applicable).

 

Related Party Policy

 

We have not yet adopted a formal policy for the review, approval or ratification of related party transactions. Accordingly, the transactions discussed above were not reviewed, approved or ratified in accordance with any such policy.

 

We have adopted a code of ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions approved by our Board of Directors (or the appropriate committee of our board) or as disclosed in our public filings with the SEC. Under our code of ethics, conflict of interest situations will include any financial transaction, arrangement or relationship (including any indebtedness or guarantee of indebtedness) involving the Company. You will be able to review these documents by accessing our public filings at the SEC’s web site at www.sec.gov. In addition, a copy of the Code of Ethics will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our Code of Ethics in a Current Report on Form 8-K.

 

31

 

 

In addition, our audit committee, pursuant to a written charter that we have adopted prior to the consummation of our IPO, is responsible for reviewing and approving related party transactions to the extent that we enter into such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum is present will be required in order to approve a related party transaction. A majority of the members of the entire audit committee will constitute a quorum. Without a meeting, the unanimous written consent of all of the members of the audit committee will be required to approve a related party transaction. We also require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits information about related party transactions.

 

These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer.

 

To further minimize conflicts of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our Sponsor, officers or directors unless we, or a committee of independent directors, have obtained an opinion from an independent investment banking firm or another independent firm that commonly renders valuation opinions for the type of company we are seeking to acquire or an independent accounting firm, that our initial business combination is fair to our company from a financial point of view. Furthermore, no finder’s fees, reimbursements or cash payments will be made to our Sponsor, officers or directors, or our or their affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination. However, the following payments will be made to our Sponsor, officers or directors, or our or their affiliates, none of which will be made from the proceeds of our IPO held in the trust account prior to the completion of our initial business combination:

 

  Repayment of up to an aggregate of up to $300,000 in loans, if any, made to us by our Sponsor to cover offering-related and organizational expenses;
     
  Payment to an affiliate of our Sponsor of $10,000 per month, for up to 9 months (or up to 18 months from the closing of our IPO if we extend the period of time to consummate a business combination by the full amount of time), for office space, utilities and secretarial and administrative support;
     
  Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and
     
  Repayment of non-interest bearing loans which may be made by our Sponsor or an affiliate of our Sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination and repayment of non-interest bearing loans which may be made by our Sponsor or its affiliates to extend our time period for consummating a business combination, the terms of which (other than as described above) have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of the loans made by our Sponsor, our officers and directors, or our or their affiliates to us prior to or in connection with our initial business combination may be convertible into Units, at a price of $10.00 per Unit at the option of the lender, upon consummation of our initial business combination. The Units would be identical to the Placement Units.

 

Our audit committee will review on a quarterly basis all payments that were made to our Sponsor, officers or directors, or our or their affiliates.

 

Director Independence

 

The Nasdaq listing standards require that a majority of our Board of Directors be independent. An “independent director” is defined generally as a person who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization that has a relationship with the company). Our board has determined that each of Cathy Jiang, Joel Mayersohn and Brian Hartzband is an independent director under applicable SEC and Nasdaq rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present.

 

32

 

 

Item 14. Principal Accounting Fees and Services.

 

The following is a summary of fees paid or to be paid to Marcum LLP (“Marcum”) for services rendered.

 

Audit Fees. Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and services that are normally provided by Marcum in connection with regulatory filings. The aggregate fees billed by Marcum for professional services rendered for the audit of our annual financial statements, review of the financial information included in our Forms 10-Q for the respective periods and other required filings with the SEC for the period from March 1, 2021 (inception) through December 31, 2022 total $59,740 The above amounts include interim procedures and audit fees, as well as attendance at audit committee meetings.

 

Audit-Related Fees. Audit-related services consist of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements and are not reported under “Audit Fees.” We did not pay Marcum for professional services rendered for audit related fees for the period from March 1, 2021 (inception) through December 31, 2022.

 

Tax Fees. We did not pay Marcum for tax planning and tax advice for the period from March 1, 2021 (inception) through December 31, 2022.

 

All Other Fees. We did not pay Marcum for other services for the period from March 1, 2021 (inception) through December 31, 2022.

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules.

 

1. The following documents are filed as part of this Annual Report:

 

Financial Statements: See “Item 8. Financial Statements and Supplementary Data” herein and “Index to Financial Statements” and financial statements incorporated by reference therein commencing below.

 

2. Exhibits: The following exhibits are filed as part of, or incorporated by reference into, this Annual Report on Form 10-K.

 

33

 

 

Exhibit Number   Description
3.1   Amended and Restated Memorandum and Articles of Association (incorporated herein by reference to Exhibit 3.1 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
4.1   Specimen Unit Certificate (incorporated herein by reference to Exhibit 4.1 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
4.2   Specimen Ordinary Share Certificate (incorporated herein by reference to Exhibit 4.2 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
4.3   Specimen Right Certificate (incorporated herein by reference to Exhibit 4.3 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)

 

4.4   Rights Agreement, dated October 13, 2022, by and between the Registrant and American Stock Transfer & Trust Company, LLC (incorporated herein by reference to Exhibit 4.1 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
10.1   Letter Agreement, dated October 13, 2022, by and among the Registrant, its officers and directors, and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.1 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
10.2   Investment Management Trust Agreement, dated October 13, 2022, by and between the Registrant and American Stock Transfer & Trust Company, LLC (incorporated herein by reference to Exhibit 10.2 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
10.3   Registration Rights Agreement, dated October 13, 2022, by and between the Registrant and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.3 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
10.4   Private Placement Unit Subscription Agreement, dated October 13, 2022, by and between the Registrant and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.4 to Form 8-K as filed with the Securities and Exchange Commission on October 19, 2022)
     
10.5   Securities Subscription Agreement, dated March 24, 2021, by and between the Registrant and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.5 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
10.6   Amended and Restated Securities Subscription Agreement, dated December 20, 2021, by and between the Registrant and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.10 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
10.7   Form of Administrative Services Agreement, by and between the Registrant and 10XYZ Holdings LP (incorporated herein by reference to Exhibit 10.8 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
14   Form of Code of Ethics (incorporated herein by reference to Exhibit 14 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
99.1   Form of Audit Committee Charter (incorporated herein by reference to Exhibit 99.1 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)
     
99.2   Form of Compensation Committee Charter (incorporated herein by reference to Exhibit 99.2 to Form S-1 as filed with the Securities and Exchange Commission on September 12, 2022)

 

34

 

 

31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   Inline XBRL Instance Document – the Inline XBRL Instance Document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

Item 16. Form 10-K Summary.

 

None.

 

35

 

 

SIGNATURE

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  TENX KEANE ACQUISITION
   
Date: April 17, 2023  
  By: /s/ Xiaofeng Yuan
    Xiaofeng Yuan
    Chief Executive Officer and Chairman
    (Principal Executive Officer)
     
  By: /s/ Taylor Zhang
    Taylor Zhang
    Chief Financial Officer and Director
    (Principal Financial Officer and Accounting Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Name   Position   Date
         
/s/ Xiaofeng Yuan   Chief Executive Officer and Chairman   April 17, 2023
Xiaofeng Yuan   (Principle Executive Officer)    
         
/s/ Taylor Zhang   Chief Financial Officer and Director   April 17, 2023
Taylor Zhang   (Principal Accounting and Financial Officer)    
         
/s/ Cathy Jiang   Director   April 17, 2023
Cathy Jiang        
         
/s/ Joel Mayersohn   Director   April 17, 2023
Alfred “Trey” Hickey        
         
/s/ Brian Hartzband   Director   April 17, 2023
Brian Hartzband        

 

36
 

 

TenX Keane Acquisition

FOR THE YEAR ENDED DECEMBER 31, 2022

 

  Page
Financial Statements  
Report of Independent Registered Public Accounting Firm (PCAOB #688) F-1
Balance Sheets as of December 31, 2022 and 2021 F-2
Statements of Operations for the Year ended December 31, 2022, and for the period from March 1, 2021 (inception) through December 31, 2021 F-3
Statements of Changes in Shareholders’ Deficit for the Year ended December 31, 2022 and for the period from March 1, 2021 (inception) through December 31, 2021 F-4
Statements of Cash Flows for the Year ended December 31, 2022, for the period from March 1, 2021 (inception) through December 31, 2021 F-5
Notes to Financial Statements F-6

 

37
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of (the “Company”) as of December 31, 2022 and 2021, the related statements of operations, shareholders’ equity (deficit) and cash flows the year ended December 31, 2022 and for the period from March 1, 2021 (inception) through December 31, 2021, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for the year ended December 31, 2022 and for the period from March 1, 2021 (inception) through December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. In addition, if the Company is unable to complete a business combination by July 18, 2023, then the Company will cease all operations except for the purpose of liquidating. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ Marcum LLP

 

Marcum llp

 

We have served as the Company’s auditor since 2021.

 

West Palm Beach, Florida

 

April 17, 2023

 

F-1

 

 

TENX KEANE ACQUISITION

BALANCE SHEETS

 

  

December 31,

2022

  

December 31,

2021

 
         
ASSETS          
Current Assets:          
Cash  $289,175   $ 
Prepaid expenses   88,169     
Deferred offering costs       126,422 
Total Current Assets   377,344    126,422 
Investments held in trust account   67,813,020     
Total Assets  $68,190,364   $126,422 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)          
Current Liabilities:          
Accrued formation costs  $31,836   $5,848 
Due to related party       130,687 
Total Current Liabilities   31,836    136,535 
           
Commitments and contingencies   -    -  
           
Ordinary shares subject to possible redemption (6,600,000 shares at $10.27 per share)   67,813,020     
           
Shareholders’ Deficit:          
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding        
Ordinary shares, $0.0001 par value; 150,000,000 shares authorized;          
2,416,000 shares issued and outstanding (excluding 6,600,000 shares subject to possible redemption)   242    173 
Additional paid-in capital       24,827 
Shareholder receivable       (25,000)
Retained earnings (accumulated deficit)   345,266    (10,113)
Total Shareholders’ Equity (Deficit)   345,508    (10,113)
Total Liabilities and Shareholders’ Equity (Deficit)  $68,190,364   $126,422 

 

The accompanying notes are an integral part of these financial statements.

 

F-2

 

 

TENX KEANE ACQUISITION

STATEMENTS OF OPERATIONS

 

   FOR THE
YEAR
ENDED
DECEMBER 31,
2022
   FOR THE
PERIOD
FROM
MARCH 1,
2021
(INCEPTION)
THROUGH
DECEMBER 31,
2021
 
General and administrative costs  $138,115   $10,113 
Operating loss   (138,115)   (10,113)
           
Other Income          
           
Interest income on investments held in trust account   493,020     
Change in derivative liability   25,906     
Total other income   518,926     
           
Net income (loss)  $380,811   $(10,113)
           
Weighted average ordinary shares outstanding, basic and diluted for ordinary shares not subject to redemption   1,865,478    1,725,000 
Basic and diluted net income (loss) per ordinary share for ordinary shares not subject to redemption  $0.12   $

(0.01

)

Weighted average ordinary shares outstanding, basic and diluted for ordinary shares subject to redemption

   1,341,758    - 
           
Basic and diluted net income (loss) per ordinary share for ordinary shares subject to redemption  $0.12   $- 

 

The accompanying notes are an integral part of these financial statements.

 

F-3

 

 

TENX KEANE ACQUISITION

STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

For the YEAR ended DECEMBER 31, 2022

 

   Shares   Amount   Capital   Receivable   Earnings   (Deficit) 
   Ordinary Shares   Additional Paid-in   Shareholder  

(Accumulated Deficit)

Retained

  

Total Shareholders’

Equity

 
   Shares   Amount   Capital   Receivable   Earnings   (Deficit) 
Balance, January 1, 2022   1,725,000   $173   $24,827   $(25,000)  $(10,113)  $(10,113)
Payment for founder shares               25,000        25,000 
Private placement rights proceeds   394,000    39    3,939,961            3,940,000 
Fair value of public rights   1,056,000                        1,056,000 
Fair value of underwriter shares   297,000    30    2,922,450            2,922,480 
Issuance costs            (343,845)             (343,845)
Remeasurement of ordinary shares subject to redemption             (7,599,393)        (25,432)   (7,624,825)
Net income                   380,811    380,811 
Balance, December 31, 2022   2,416,000   $242   $   $   $345,266   $345,508 

 

For the PERIOD FROM MARCH 1, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021

 

   Ordinary Shares   Additional Paid-in   Shareholder   Accumulated   Total Shareholders’ 
   Shares   Amount   Capital   Receivable   Deficit   Deficit 
Balance, March 1, 2021      $   $   $   $   $ 
Issuance of ordinary shares to Sponsor   1,725,000    173    24,827   $(25,000)        
Net loss                       (10,113)   (10,113)
Balance, December 31, 2021   1,725,000   $173   $24,827   $(25,000)  $(10,113)  $(10,113)

 

The accompanying notes are an integral part of these financial statements.

 

F-4

 

 

TENX KEANE ACQUISITION

STATEMENTS OF CASH FLOWS

 

  

FOR THE

YEAR ENDED

DECEMBER 30,

2022

  

FOR THE

PERIOD FROM

MARCH 1, 2021

(INCEPTION)

THROUGH

DECEMBER 31,
2021

 
Cash flows from operating activities:          
Net income (loss)  $380,811   $(10,113)
Adjustments to reconcile net loss to net cash used in operating activities:          
Interest income on investments held in trust account   (493,020)    
Change in operating assets and liabilities:          
Prepaid expenses   (88,169)    
Formation and organization costs paid by related parties        10,113 
Deferred offering costs   126,422     
Accrued expenses   25,988      
Net cash used in operating activities   (47,968)    
           
Cash flows from investing activities:          
Cash deposited into trust account   (67,320,000)    
Net cash used in investing activities   (67,320,000)     
           
Cash flows from financing activities:          
Sale of ordinary shares   66,000,000     
Net proceeds from sale of private placement ordinary shares   3,335,987     
Underwriting fee   (1,320,000)    
Other fees   (253,157)    
Proceeds from issuance ordinary shares to sponsor   25,000     
Repayment of sponsor note   (130,687)    
Net cash provided by financing activities   67,657,143     
           
Net change in cash   289,175     
Cash at beginning of period        
Cash at end of period  $289,175   $ 
           
Non-cash financing activities:          
Remeasurement of ordinary shares subject to redemption  $7,624,825   $- 
Deferred offering costs included in due to related party  $   $126,422 

 

The accompanying notes are an integral part of these financial statements.

 

F-5

 

 

TENX KEANE ACQUISITION

Notes to the financial statements

 

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

 

TenX Keane Acquisition (the “Company”) was incorporated in the Cayman Islands on March 1, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of December 31, 2022, the Company had not commenced any operations. All activity for the period from March 1, 2021 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed Public Offering. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on October 13, 2022. On October 18, 2022, the Company consummated the Initial Public Offering of 6,600,000 units, including 600,000 additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option, (“Units” and, with respect to the common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $66,000,000, which is described in Note 3.

 

Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 394,000 Units (the “Placement Units”), to the 10XYZ Holdings LP (the “Sponsor”) at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000.

 

As of October 18, 2022, transaction costs amounted to $4,859,330 consisting of $1,320,000 of cash underwriting fees, non-cash underwriting fees of $2,922,480 represented by the fair value of 297,000 shares issued to the underwriter and $616,850 of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the Initial Public Offering.

 

Following the closing of the Initial Public Offering on October 18, 2022, an amount of $67,320,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 4) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering, management has agreed that $10.00 per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

 

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).

 

F-6

 

 

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to immediate fair value recognition. The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.

 

The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Proposed Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

 

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.

 

F-7

 

 

The Company will have until 9 months (or 18 months if the Company extends the period) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Going Concern Consideration

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that the funds which the Company has available following the completion of the Initial Public Offering will enable it to sustain operations for a period of at least one-year from the issuance date of this financial statement. However, management has determined that the combination period is less than one year from the date of the issuance of the financial statements. There is no assurance that the Company’s plans to consummate a business combination will be successful within the combination period. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

F-8

 

 

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Public Offering and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents at December 31, 2022 and 2021.

 

Deferred Offering Costs

 

Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. As of December 31, 2022 and 2021 the Company had deferred offering costs of $0, and $126,422, respectively.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

F-9

 

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for the ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480, “Distinguishing Liabilities from Equity.” Shares of the common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of the common stock (including shares of the common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the issuer’s control) are classified as temporary equity. At all other times, shares of the common stock are classified as stockholders’ equity. The ordinary features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, the ordinary shares subject to possible redemption in the amount of $67,813,020 and $0, respectively, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

 

As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:

 

      
Gross proceeds  $66,000,000 
Proceeds allocated to public rights   (1,056,000)
Offering costs allocated ordinary shares subject to redemption   (4,755,805)
Remeasurement of ordinary shares subject to redemption  $7,624,825 
Ordinary shares subject to possible redemption  $67,813,020 

 

Net income (loss) per share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.

 

The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.

 

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

 

  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
   For the Year 
   Ended December 31, 2022 
  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
Basic and diluted net income per share          
Numerator:          
Allocation of net income  $159,314   $221,497 
Denominator:          
Basic and diluted weighted average shares outstanding   1,341,758    1,865,478 
           
Basic and diluted net income per share  $0.12   $0.12 

 

     
     
   For the Year Ended December 31, 2021 
   Ordinary Shares 
Basic and diluted net income per share     
Numerator:     
Net income (loss)  $(10,113)
Denominator:     
Basic and diluted weighted average shares outstanding   1,725,000 
      
Basic and diluted net income per share  $(0.01)

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.

 

F-10

 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

 

Financial Instruments

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

 

Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.

 

Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 Inputs: Significant inputs into the valuation model are unobservable.

 

The Company does not have any recurring Level 2 assets or liabilities, see Note 8 for Level 3 assets and liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.

 

Recent Accounting Standards

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”),” which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

 

NOTE 3 — INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 6,600,000 Units, including 600,000 additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option at a price of $10.00 per Unit. Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the holder to one share of ordinary shares (see Note 7).

 

NOTE 4 — PRIVATE PLACEMENTS

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale of 394,000 Private Placement Units. Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units and Private Rights (including the ordinary shares issuable upon exercise of the Private Rights) will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain exceptions.

 

F-11

 

 

NOTE 5 — RELATED PARTIES

 

Founder Shares

 

On March 24, 2021, the Sponsor received 1,437,500 of the Company’s ordinary shares (the “Founder Shares”) in exchange for $25,000 to be paid at a later date. On December 20, 2021, the board of directors of the Company and our sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:

 

  (a) Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each;
  (b) Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each; and
  (c) Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.

 

On December 20, 2021, subsequent to the above share exchange the Company issued an additional 287,500 ordinary shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of 1,725,000 ordinary shares (the founder shares). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The founder shares include an aggregate of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. On October 18, 2022, the underwriter partially exercised the over-allotment and as such, as of November 28, 2022, 150,000 ordinary shares are not subject to forfeiture.

 

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property.

 

Promissory Note — Related Party

 

On March 17, 2021, the Sponsor issued an unsecured promissory note (the “Pre-IPO Note”) to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) September 30, 2022 or (ii) the consummation of the Proposed Public Offering. As of December 31, 2022 and December 31, 2021, there were no amounts outstanding under the Promissory Note. After expiration of the Promissory Note, the Sponsor issued a new unsecured promissory note to the Company (the “Post-IPO Promissory Note”) on April 14, 2023. The Post-IPO Promissory Note is non-interest bearing and payable on the earlier of (i) April 14, 2024 or (ii) the date of consummation of the Company’s initial business combination or liquidation (such earlier date, the “Maturity Date”).

 

Advances from Related Party

 

The Sponsor paid certain formation and operating costs on behalf of the Company. These advances are due on demand and non-interest bearing. As of December 31, 2022 and 2021, the amount due to the Sponsor was $0 and $130,687, respectively.

 

Administrative Services Agreement

 

Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company has incurred expense of $21,666 for the year ended December 31, 2022. No expense was incurred in 2021.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted into units, at the price of $10.00 per unit at the option of the lender. Such units would be identical to the Private Placement Units In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there were no amounts outstanding under the Working Capital Loans.

 

F-12

 

 

NOTE 6 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and any shares of ordinary shares issuable upon the exercise of the Private Placement Right) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 900,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriter partially exercised the over-allotment in the amount of 600,000 Units during the option period.

 

The underwriters are entitled to a cash underwriting discount of $0.20 per Unit payable upon the closing of the Initial Public Offering.

 

The underwriters are also entitled to 270,000 ordinary shares (310,500 if the over-allotment option is exercised in full) as part of its underwriting fee. Due to the partial exercise, the shares granted at October 18, 2022 were 297,000.

 

NOTE 7 — SHAREHOLDERS’ EQUITY (DEFICIT)

 

Preferred Shares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2022 and 2021, there were no shares of preferred shares issued or outstanding.

 

Ordinary Shares — The Company is authorized to issue 150,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share.

 

As of December 31, 2022 and 2021, there were 1,725,000 ordinary shares issued and outstanding, of which an aggregate of up to 225,000 ordinary shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part so that the number of Founder Shares will equal 19% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding private placement shares) or approximately 23.0% (including private placement shares). The underwriter partially exercised the over-allotment and as such 150,000 ordinary shares are not subject to forfeiture as of October 18, 2022.

 

Only holders of the founder shares will have the right to vote on the election of directors prior to the Business Combination. Holders of ordinary shares and holders of founder shares will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a shareholders’ agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.

 

F-13

 

 

In the case that additional shares of ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Public Offering and relate to the closing of a Business Combination, the ratio at which founder shares will be adjusted (unless the holders of a majority of the then-outstanding shares of founder shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of founder shares will equal, in the aggregate, 19% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of Proposed Public Offering plus all shares of ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of ordinary shares redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.

 

Rights - Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive two-tenths (2/10) of one ordinary share upon consummation of the initial business combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law.

 

NOTE 8. FAIR VALUE MEASUREMENTS

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level  December 31,
2022
   December 31,
2021
 
Assets:                    
Marketable securities held in the Trust Account  1  $67,813,020   $- 

 

NOTE 9 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

 

F-14

 

EX-31.1 2 ex31-1.htm

 

Exhibit 31.1

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Xiaofeng Yuan, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2022 of TenX Keane Acquisition (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 17, 2023

 

  /s/ Xiaofeng Yuan
  Xiaofeng Yuan
 

Chief Executive Officer

  (Principal Executive Officer)

 

 

EX-31.2 3 ex31-2.htm

 

Exhibit 31.2

 

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Taylor Zhang, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the fiscal year ended December 31, 2022 of TenX Keane Acquisition (the “registrant”);
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: April 17, 2023

 

  /s/ Taylor Zhang
  Taylor Zhang
 

Chief Financial Officer

  (Principal Financial and Accounting Officer)

 

 

EX-32.1 4 ex32-1.htm

 

Exhibit 32.1

 

Certification Pursuant to 18 U.S.C. Section 1350

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Annual Report on Form 10-K of TenX Keane Acquisition (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Xiaofeng Yuan, Chief Executive Officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 17, 2023

 

  /s/ Xiaofeng Yuan
  Xiaofeng Yuan
 

Chief Executive Officer

  (Principal Executive Officer)

 

 

EX-32.2 5 ex32-2.htm

 

Exhibit 32.2

 

Certification Pursuant to 18 U.S.C. Section 1350

as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with the Annual Report on Form 10-K of TenX Keane Acquisition (the “Company”), as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Taylor Zhang, Chief Financial Officer of the Company, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: April 17, 2023

 

  /s/ Taylor Zhang
  Taylor Zhang
 

Chief Financial Officer

  (Principal Financial and Accounting Officer)

 

 

EX-101.SCH 6 tenku-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Changes In Shareholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INITIAL PUBLIC OFFERING link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - PRIVATE PLACEMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - SHAREHOLDERS’ EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - PRIVATE PLACEMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SHAREHOLDERS’ EQUITY (DEFICIT) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 tenku-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 tenku-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 tenku-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Units Each Consisting Of One Ordinary Share 0.0001 Par Value [Member] Ordinary Shares Par Value 0.0001 Per Share [Member] Rights Each Right Entitling Holder To Receive Twotenths Of One Ordinary Share [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Shareholder Receivable [Member] Retained Earnings [Member] Sale of Stock [Axis] IPO [Member] Over-Allotment Option [Member] Title of Individual [Axis] Underwriter [Member] Private Placement [Member] Related Party Transaction [Axis] Sponsor [Member] Public Shareholders [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Ordinary Shares Subject To Redemption [Member] Ordinary Shares Not Subject To Redemption [Member] Award Type [Axis] To Be Paid Later [Member] Common Class A [Member] Common Class B [Member] Related Party [Axis] Debt Instrument [Axis] Unsecured Promissory Note [Member] Working Capital Loan [Member] Underwriters [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current Assets: Cash Prepaid expenses Deferred offering costs Total Current Assets Investments held in trust account Total Assets LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) Current Liabilities: Accrued formation costs Due to related party Total Current Liabilities Commitments and contingencies Ordinary shares subject to possible redemption (6,600,000 shares at $10.27 per share) Shareholders’ Deficit: Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 2,416,000 shares issued and outstanding (excluding 6,600,000 shares subject to possible redemption) Additional paid-in capital Shareholder receivable Retained earnings (accumulated deficit) Total Shareholders’ Equity (Deficit) Total Liabilities and Shareholders’ Equity (Deficit) Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares Temporary Equity, Par or Stated Value Per Share Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Ordinary shares, par value Ordinary shares, shares authorized Ordinary shares, shares issued Ordinary shares, shares outstanding Common stock, shares subject to possible redemption Income Statement [Abstract] General and administrative costs Operating loss Other Income Interest income on investments held in trust account Change in derivative liability Total other income Net income (loss) Weighted average ordinary shares outstanding, basic and diluted for ordinary shares not subject to redemption Basic and diluted net income (loss) per ordinary share for ordinary shares not subject to redemption Weighted average ordinary shares outstanding, basic and diluted for ordinary shares subject to redemption Basic and diluted net income (loss) per ordinary share for ordinary shares subject to redemption Beginning balance, value Beginning balance, shares Payment for founder shares Private placement rights proceeds Private placement rights proceeds, shares Fair value of public rights Fair value of public rights, shares Fair value of underwriter shares Fair value of underwriter shares, shares Issuance costs Remeasurement of ordinary shares subject to redemption Net income (loss) Issuance of ordinary shares to Sponsor Issuance of ordinary shares to Sponsor, shares Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Interest income on investments held in trust account Change in operating assets and liabilities: Prepaid expenses Formation and organization costs paid by related parties Deferred offering costs Accrued expenses Net cash used in operating activities Cash flows from investing activities: Cash deposited into trust account Net cash used in investing activities Cash flows from financing activities: Sale of ordinary shares Net proceeds from sale of private placement ordinary shares Underwriting fee Other fees Proceeds from issuance ordinary shares to sponsor Repayment of sponsor note Net cash provided by financing activities Net change in cash Cash at beginning of period Cash at end of period Non-cash financing activities: Remeasurement of ordinary shares subject to redemption Deferred offering costs included in due to related party Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Initial Public Offering INITIAL PUBLIC OFFERING Private Placements PRIVATE PLACEMENTS Related Party Transactions [Abstract] RELATED PARTIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHAREHOLDERS’ EQUITY (DEFICIT) Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of Presentation Emerging Growth Company Use of Estimates Cash and cash equivalents Deferred Offering Costs Income Taxes Ordinary Shares Subject to Possible Redemption Net income (loss) per share Derivative Financial Instruments Concentration of Credit Risk Financial Instruments Recent Accounting Standards SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE Stock issued during period shares new issues Proceeds from initial public offering, costs Price per share Proceeds from private placement Transaction costs Cash underwriting fees Non-cash underwriting fees Other offering costs Condition for future business combination use of proceeds percentage Condition for future business combination threshold percentage ownership Net tangible assets upon redemption of business combinations Redemption limit percentage without prior written consent Percentage obligation to redeem public shares if entity does not complete business combination Maximum allowed dissolution expenses Gross proceeds Proceeds allocated to public rights Offering costs allocated ordinary shares subject to redemption Remeasurement of ordinary shares subject to redemption Ordinary shares subject to possible redemption Basic and diluted weighted average shares outstanding Basic and diluted net income per share Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Cash equivalents Unrecognized tax benefits Amounts accrued for interest and penalties Ordinary shares subject to possible redemption FDIC insured amount Sale of stock shares issued in transaction Ordinary share conversion basis Private sale of private placement units Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Ordinary shares exchanged in consideration for issuance Exchange amounts transaction Common stock, authorized but unissued Common stock, par value Shares issued price per share Common stock, shares outstanding Ordinary shares forfeiture Sale of stock price per share Aggregate principal amount Due to related parties, current Sponsor fees Administrative service expenses Repayments of related party debt Share price Working capital loans Stock repurchased during period, shares Stock issued during period shares option exercised Aggregate underwriting discount Number of shares granted Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Preferred stock, par or stated value per share Common stock, stock authorized Common stock, shares issued Common stock shares not subject to forfeiture Percentage of issued and outstanding shares Outstanding percentage Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Marketable securities held in the Trust Account Rights Each Right Entitling Holder To Receive Twotenths Of One Ordinary Share [Member] Ordinary Shares Par Value 0.0001 Per Share [Member] Units Each Consisting Of One Ordinary Share 0.0001 Par Value [Member] Emerging Growth Company [Policy Text Block] Initial Public Offering [Text Block] Disclosure of Private Placement [Text Block] Accrued formation costs current. Underwriter [Member] Percentage of issued and outstanding shares. Sponsor [Member] Underwriters [Member] Underwriting commitments per share. To Be Paid Later [Member] Unsecured Promissory Note [Member] Shareholder receivable. Working Capital Loan [Member] Working capital loans. Change in derivative liability. Shareholder Receivable [Member] Ordinary Shares Subject To Redemption [Member] Ordinary Shares Not Subject To Redemption [Member] Adjustments to additional paid in capital remeasurement of ordinary shares subject to redemption. Stock issued during period value underwriter shares. Stock issued during period shares underwriter shares Increase decrease formation and organization costs paid by related parties. Deferred offering costs included in accrued expenses. Deferred offering costs included in due to related party. Payments for non cash underwriting expense. Other offering costs. Condition for future business combination threshold percentage ownership. Condition for future business combination use of proceeds percentage. Public Shareholders [Member] Net tangible assets upon redemption of business combinations. Redemption limit percentage without prior written consent. Percentage obligation to redeem public shares if entity does not complete business combination. Maximum allowed dissolution expenses. Interest income on investments held in trust account. Common stock shares subject to mandatory redemption number of shares. Payments for underwriting fees. Payments for other fees. Temporary equity accrued interest in trust. Temporary equity deposited in trust F par or stated value per share. Stock issued during period value fair value of public rights. Stock issued during period shares fair value of public rights. Remeasurement of ordinary shares subject to redemption. Offering costs allocated ordinary shares subject to redemption. Proceeds allocated to public rights. Stock issued during period value fair value of underwriter shares. Stock issued during period shares fair value of underwriter shares. Assets, Current Assets Liabilities, Current Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Income (Loss) Nonoperating Income (Expense) Shares, Outstanding Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Increase (Decrease) in Prepaid Expense Increase (Decrease) in Deferred Revenue Net Cash Provided by (Used in) Operating Activities Payments to Acquire Other Investments Net Cash Provided by (Used in) Investing Activities PaymentsForUnderwritingFees PaymentsForOtherFees Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations RemeasurementOfOrdinarySharesSubjectToRedemption TemporaryEquityAccruedInterestInTrust EX-101.PRE 10 tenku-20221231_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Apr. 17, 2023
Jun. 30, 2022
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2022    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2022    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41534    
Entity Registrant Name TenX Keane Acquisition    
Entity Central Index Key 0001851484    
Entity Incorporation, State or Country Code E9    
Entity Address, Address Line One 420 Lexington Avenue    
Entity Address, Address Line Two Suite 2446    
Entity Address, City or Town New York    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 10170    
City Area Code (347)    
Local Phone Number 627-0058    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company true    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   8,941,000  
ICFR Auditor Attestation Flag false    
Auditor Firm ID 688    
Auditor Name Marcum LLP    
Auditor Location West Palm Beach, Florida    
Units Each Consisting Of One Ordinary Share 0.0001 Par Value [Member]      
Title of 12(b) Security Units, each consisting of one ordinary share, $0.0001 par value, and one right entitling the holder to receive two-tenths of an ordinary share    
Trading Symbol TENKU    
Security Exchange Name NASDAQ    
Ordinary Shares Par Value 0.0001 Per Share [Member]      
Title of 12(b) Security Ordinary shares, par value $0.0001 per share    
Trading Symbol TENK    
Security Exchange Name NASDAQ    
Rights Each Right Entitling Holder To Receive Twotenths Of One Ordinary Share [Member]      
Title of 12(b) Security Rights, each right entitling the holder to receive two-tenths of one ordinary share    
Trading Symbol TENKR    
Security Exchange Name NASDAQ    
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 289,175
Prepaid expenses 88,169
Deferred offering costs 126,422
Total Current Assets 377,344 126,422
Investments held in trust account 67,813,020
Total Assets 68,190,364 126,422
Current Liabilities:    
Accrued formation costs 31,836 5,848
Due to related party 130,687
Total Current Liabilities 31,836 136,535
Commitments and contingencies
Ordinary shares subject to possible redemption (6,600,000 shares at $10.27 per share) 67,813,020
Shareholders’ Deficit:    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 2,416,000 shares issued and outstanding (excluding 6,600,000 shares subject to possible redemption) 242 173
Additional paid-in capital 24,827
Shareholder receivable (25,000)
Retained earnings (accumulated deficit) 345,266 (10,113)
Total Shareholders’ Equity (Deficit) 345,508 (10,113)
Total Liabilities and Shareholders’ Equity (Deficit) $ 68,190,364 $ 126,422
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares   6,600,000
Temporary Equity, Par or Stated Value Per Share   $ 10.27
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 1,000,000 1,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Ordinary shares, par value $ 0.0001 $ 0.0001
Ordinary shares, shares authorized 150,000,000 150,000,000
Ordinary shares, shares issued 2,416,000 2,416,000
Ordinary shares, shares outstanding 2,416,000 2,416,000
Common stock, shares subject to possible redemption 6,600,000 6,600,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Operations - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Income Statement [Abstract]    
General and administrative costs $ 10,113 $ 138,115
Operating loss (10,113) (138,115)
Other Income    
Interest income on investments held in trust account 493,020
Change in derivative liability 25,906
Total other income 518,926
Net income (loss) $ (10,113) $ 380,811
Weighted average ordinary shares outstanding, basic and diluted for ordinary shares not subject to redemption 1,725,000 1,865,478
Basic and diluted net income (loss) per ordinary share for ordinary shares not subject to redemption $ (0.01) $ 0.12
Weighted average ordinary shares outstanding, basic and diluted for ordinary shares subject to redemption 1,341,758
Basic and diluted net income (loss) per ordinary share for ordinary shares subject to redemption $ 0.12
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Changes In Shareholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Shareholder Receivable [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Feb. 28, 2021
Beginning balance, shares at Feb. 28, 2021        
Net income (loss)       (10,113) (10,113)
Issuance of ordinary shares to Sponsor $ 173 24,827 (25,000)
Issuance of ordinary shares to Sponsor, shares 1,725,000        
Ending balance, value at Dec. 31, 2021 $ 173 24,827 (25,000) (10,113) (10,113)
Ending balance, shares at Dec. 31, 2021 1,725,000        
Payment for founder shares 25,000 25,000
Private placement rights proceeds $ 39 3,939,961 3,940,000
Private placement rights proceeds, shares 394,000        
Fair value of public rights         1,056,000
Fair value of public rights, shares 1,056,000        
Fair value of underwriter shares $ 30 2,922,450 2,922,480
Fair value of underwriter shares, shares 297,000        
Issuance costs   (343,845)     (343,845)
Remeasurement of ordinary shares subject to redemption   (7,599,393)   (25,432) (7,624,825)
Net income (loss) 380,811 380,811
Ending balance, value at Dec. 31, 2022 $ 242 $ 345,266 $ 345,508
Ending balance, shares at Dec. 31, 2022 2,416,000        
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Cash flows from operating activities:    
Net income (loss) $ (10,113) $ 380,811
Adjustments to reconcile net loss to net cash used in operating activities:    
Interest income on investments held in trust account (493,020)
Change in operating assets and liabilities:    
Prepaid expenses (88,169)
Formation and organization costs paid by related parties 10,113  
Deferred offering costs   126,422
Accrued expenses   25,988
Net cash used in operating activities (47,968)
Cash flows from investing activities:    
Cash deposited into trust account (67,320,000)
Net cash used in investing activities (67,320,000)
Cash flows from financing activities:    
Sale of ordinary shares 66,000,000
Net proceeds from sale of private placement ordinary shares 3,335,987
Underwriting fee (1,320,000)
Other fees (253,157)
Proceeds from issuance ordinary shares to sponsor 25,000
Repayment of sponsor note (130,687)
Net cash provided by financing activities 67,657,143
Net change in cash 289,175
Cash at beginning of period
Cash at end of period 289,175
Non-cash financing activities:    
Remeasurement of ordinary shares subject to redemption 7,624,825
Deferred offering costs included in due to related party $ 126,422
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN

 

TenX Keane Acquisition (the “Company”) was incorporated in the Cayman Islands on March 1, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

 

The Company is not limited to a particular industry or sector for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of December 31, 2022, the Company had not commenced any operations. All activity for the period from March 1, 2021 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed Public Offering. The Company has selected December 31 as its fiscal year end.

 

The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on October 13, 2022. On October 18, 2022, the Company consummated the Initial Public Offering of 6,600,000 units, including 600,000 additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option, (“Units” and, with respect to the common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $66,000,000, which is described in Note 3.

 

Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 394,000 Units (the “Placement Units”), to the 10XYZ Holdings LP (the “Sponsor”) at a price of $10.00 per Placement Unit, generating total proceeds of $3,940,000.

 

As of October 18, 2022, transaction costs amounted to $4,859,330 consisting of $1,320,000 of cash underwriting fees, non-cash underwriting fees of $2,922,480 represented by the fair value of 297,000 shares issued to the underwriter and $616,850 of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the Initial Public Offering.

 

Following the closing of the Initial Public Offering on October 18, 2022, an amount of $67,320,000 ($10.20 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 4) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (as defined below) (excluding the taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering, management has agreed that $10.00 per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.

 

The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).

 

 

All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to immediate fair value recognition. The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $5,000,001, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.

 

The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Proposed Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.

 

The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.

 

 

The Company will have until 9 months (or 18 months if the Company extends the period) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($10.00).

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

 

Going Concern Consideration

 

In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management believes that the funds which the Company has available following the completion of the Initial Public Offering will enable it to sustain operations for a period of at least one-year from the issuance date of this financial statement. However, management has determined that the combination period is less than one year from the date of the issuance of the financial statements. There is no assurance that the Company’s plans to consummate a business combination will be successful within the combination period. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

 

Risks and Uncertainties

 

Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Public Offering and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents at December 31, 2022 and 2021.

 

Deferred Offering Costs

 

Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. As of December 31, 2022 and 2021 the Company had deferred offering costs of $0, and $126,422, respectively.

 

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for the ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480, “Distinguishing Liabilities from Equity.” Shares of the common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of the common stock (including shares of the common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the issuer’s control) are classified as temporary equity. At all other times, shares of the common stock are classified as stockholders’ equity. The ordinary features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, the ordinary shares subject to possible redemption in the amount of $67,813,020 and $0, respectively, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

 

As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:

 

      
Gross proceeds  $66,000,000 
Proceeds allocated to public rights   (1,056,000)
Offering costs allocated ordinary shares subject to redemption   (4,755,805)
Remeasurement of ordinary shares subject to redemption  $7,624,825 
Ordinary shares subject to possible redemption  $67,813,020 

 

Net income (loss) per share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.

 

The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.

 

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

 

  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
   For the Year 
   Ended December 31, 2022 
  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
Basic and diluted net income per share          
Numerator:          
Allocation of net income  $159,314   $221,497 
Denominator:          
Basic and diluted weighted average shares outstanding   1,341,758    1,865,478 
           
Basic and diluted net income per share  $0.12   $0.12 

 

     
     
   For the Year Ended December 31, 2021 
   Ordinary Shares 
Basic and diluted net income per share     
Numerator:     
Net income (loss)  $(10,113)
Denominator:     
Basic and diluted weighted average shares outstanding   1,725,000 
      
Basic and diluted net income per share  $(0.01)

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.

 

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

 

Financial Instruments

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

 

Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.

 

Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 Inputs: Significant inputs into the valuation model are unobservable.

 

The Company does not have any recurring Level 2 assets or liabilities, see Note 8 for Level 3 assets and liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.

 

Recent Accounting Standards

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”),” which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING
12 Months Ended
Dec. 31, 2022
Initial Public Offering  
INITIAL PUBLIC OFFERING

NOTE 3 — INITIAL PUBLIC OFFERING

 

Pursuant to the Initial Public Offering, the Company sold 6,600,000 Units, including 600,000 additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option at a price of $10.00 per Unit. Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the holder to one share of ordinary shares (see Note 7).

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENTS
12 Months Ended
Dec. 31, 2022
Private Placements  
PRIVATE PLACEMENTS

NOTE 4 — PRIVATE PLACEMENTS

 

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale of 394,000 Private Placement Units. Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units and Private Rights (including the ordinary shares issuable upon exercise of the Private Rights) will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain exceptions.

 

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTIES
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTIES

NOTE 5 — RELATED PARTIES

 

Founder Shares

 

On March 24, 2021, the Sponsor received 1,437,500 of the Company’s ordinary shares (the “Founder Shares”) in exchange for $25,000 to be paid at a later date. On December 20, 2021, the board of directors of the Company and our sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:

 

  (a) Each of the authorized but unissued 150,000,000 Class A ordinary shares were cancelled and re-designated as ordinary shares of $0.0001 par value each;
  (b) Each of the 1,437,500 Class B ordinary shares in issue were exchanged in consideration for the issuance of 1,437,500 ordinary shares of $0.0001 par value each; and
  (c) Upon completion of the above steps, the authorized but unissued 10,000,000 Class B ordinary shares were cancelled.

 

On December 20, 2021, subsequent to the above share exchange the Company issued an additional 287,500 ordinary shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of 1,725,000 ordinary shares (the founder shares). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The founder shares include an aggregate of up to 225,000 ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. On October 18, 2022, the underwriter partially exercised the over-allotment and as such, as of November 28, 2022, 150,000 ordinary shares are not subject to forfeiture.

 

The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the ordinary shares equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property.

 

Promissory Note — Related Party

 

On March 17, 2021, the Sponsor issued an unsecured promissory note (the “Pre-IPO Note”) to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is non-interest bearing and payable on the earlier of (i) September 30, 2022 or (ii) the consummation of the Proposed Public Offering. As of December 31, 2022 and December 31, 2021, there were no amounts outstanding under the Promissory Note. After expiration of the Promissory Note, the Sponsor issued a new unsecured promissory note to the Company (the “Post-IPO Promissory Note”) on April 14, 2023. The Post-IPO Promissory Note is non-interest bearing and payable on the earlier of (i) April 14, 2024 or (ii) the date of consummation of the Company’s initial business combination or liquidation (such earlier date, the “Maturity Date”).

 

Advances from Related Party

 

The Sponsor paid certain formation and operating costs on behalf of the Company. These advances are due on demand and non-interest bearing. As of December 31, 2022 and 2021, the amount due to the Sponsor was $0 and $130,687, respectively.

 

Administrative Services Agreement

 

Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company has incurred expense of $21,666 for the year ended December 31, 2022. No expense was incurred in 2021.

 

Related Party Loans

 

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted into units, at the price of $10.00 per unit at the option of the lender. Such units would be identical to the Private Placement Units In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there were no amounts outstanding under the Working Capital Loans.

 

 

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 — COMMITMENTS AND CONTINGENCIES

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and any shares of ordinary shares issuable upon the exercise of the Private Placement Right) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 900,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriter partially exercised the over-allotment in the amount of 600,000 Units during the option period.

 

The underwriters are entitled to a cash underwriting discount of $0.20 per Unit payable upon the closing of the Initial Public Offering.

 

The underwriters are also entitled to 270,000 ordinary shares (310,500 if the over-allotment option is exercised in full) as part of its underwriting fee. Due to the partial exercise, the shares granted at October 18, 2022 were 297,000.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS’ EQUITY (DEFICIT)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
SHAREHOLDERS’ EQUITY (DEFICIT)

NOTE 7 — SHAREHOLDERS’ EQUITY (DEFICIT)

 

Preferred Shares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2022 and 2021, there were no shares of preferred shares issued or outstanding.

 

Ordinary Shares — The Company is authorized to issue 150,000,000 ordinary shares with a par value of $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share.

 

As of December 31, 2022 and 2021, there were 1,725,000 ordinary shares issued and outstanding, of which an aggregate of up to 225,000 ordinary shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part so that the number of Founder Shares will equal 19% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding private placement shares) or approximately 23.0% (including private placement shares). The underwriter partially exercised the over-allotment and as such 150,000 ordinary shares are not subject to forfeiture as of October 18, 2022.

 

Only holders of the founder shares will have the right to vote on the election of directors prior to the Business Combination. Holders of ordinary shares and holders of founder shares will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a shareholders’ agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.

 

 

In the case that additional shares of ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Public Offering and relate to the closing of a Business Combination, the ratio at which founder shares will be adjusted (unless the holders of a majority of the then-outstanding shares of founder shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of founder shares will equal, in the aggregate, 19% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of Proposed Public Offering plus all shares of ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of ordinary shares redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.

 

Rights - Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive two-tenths (2/10) of one ordinary share upon consummation of the initial business combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 8. FAIR VALUE MEASUREMENTS

 

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

 

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

 

Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

 

The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level  December 31,
2022
   December 31,
2021
 
Assets:                    
Marketable securities held in the Trust Account  1  $67,813,020   $- 

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 — SUBSEQUENT EVENTS

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).

 

Emerging Growth Company

Emerging Growth Company

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

Cash and cash equivalents

Cash and cash equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents at December 31, 2022 and 2021.

 

Deferred Offering Costs

Deferred Offering Costs

 

Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. As of December 31, 2022 and 2021 the Company had deferred offering costs of $0, and $126,422, respectively.

 

Income Taxes

Income Taxes

 

The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

 

ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.

 

Ordinary Shares Subject to Possible Redemption

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for the ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480, “Distinguishing Liabilities from Equity.” Shares of the common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of the common stock (including shares of the common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the issuer’s control) are classified as temporary equity. At all other times, shares of the common stock are classified as stockholders’ equity. The ordinary features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, the ordinary shares subject to possible redemption in the amount of $67,813,020 and $0, respectively, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.

 

As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:

 

      
Gross proceeds  $66,000,000 
Proceeds allocated to public rights   (1,056,000)
Offering costs allocated ordinary shares subject to redemption   (4,755,805)
Remeasurement of ordinary shares subject to redemption  $7,624,825 
Ordinary shares subject to possible redemption  $67,813,020 

 

Net income (loss) per share

Net income (loss) per share

 

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.

 

The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.

 

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

 

  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
   For the Year 
   Ended December 31, 2022 
  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
Basic and diluted net income per share          
Numerator:          
Allocation of net income  $159,314   $221,497 
Denominator:          
Basic and diluted weighted average shares outstanding   1,341,758    1,865,478 
           
Basic and diluted net income per share  $0.12   $0.12 

 

     
     
   For the Year Ended December 31, 2021 
   Ordinary Shares 
Basic and diluted net income per share     
Numerator:     
Net income (loss)  $(10,113)
Denominator:     
Basic and diluted weighted average shares outstanding   1,725,000 
      
Basic and diluted net income per share  $(0.01)

 

Derivative Financial Instruments

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.

 

 

Concentration of Credit Risk

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account.

 

Financial Instruments

Financial Instruments

 

The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:

 

Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.

 

Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.

 

Level 3 Inputs: Significant inputs into the valuation model are unobservable.

 

The Company does not have any recurring Level 2 assets or liabilities, see Note 8 for Level 3 assets and liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.

 

Recent Accounting Standards

Recent Accounting Standards

 

In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”),” which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION

As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:

 

      
Gross proceeds  $66,000,000 
Proceeds allocated to public rights   (1,056,000)
Offering costs allocated ordinary shares subject to redemption   (4,755,805)
Remeasurement of ordinary shares subject to redemption  $7,624,825 
Ordinary shares subject to possible redemption  $67,813,020 
SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE

The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):

 

  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
   For the Year 
   Ended December 31, 2022 
  

Ordinary Shares

Subject to

Redemption

  

Ordinary Shares

Not Subject to

Redemption

 
Basic and diluted net income per share          
Numerator:          
Allocation of net income  $159,314   $221,497 
Denominator:          
Basic and diluted weighted average shares outstanding   1,341,758    1,865,478 
           
Basic and diluted net income per share  $0.12   $0.12 

 

     
     
   For the Year Ended December 31, 2021 
   Ordinary Shares 
Basic and diluted net income per share     
Numerator:     
Net income (loss)  $(10,113)
Denominator:     
Basic and diluted weighted average shares outstanding   1,725,000 
      
Basic and diluted net income per share  $(0.01)
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE

The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

 

Description  Level  December 31,
2022
   December 31,
2021
 
Assets:                    
Marketable securities held in the Trust Account  1  $67,813,020   $- 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) - USD ($)
10 Months Ended 12 Months Ended
Oct. 18, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 20, 2021
Price per share       $ 12.00
Proceeds from private placement   $ 3,335,987  
Condition for future business combination use of proceeds percentage 80.00%      
Condition for future business combination threshold percentage ownership 50.00%      
Redemption limit percentage without prior written consent 15.00%      
Percentage obligation to redeem public shares if entity does not complete business combination 100.00%      
Maximum allowed dissolution expenses $ 100,000      
Minimum [Member]        
Net tangible assets upon redemption of business combinations 5,000,001      
Maximum [Member]        
Net tangible assets upon redemption of business combinations $ 5,000,001      
Sponsor [Member]        
Price per share $ 10.00      
Sponsor [Member] | Maximum [Member]        
Price per share $ 10.00      
Common Stock [Member]        
Stock issued during period shares new issues   1,725,000    
IPO [Member]        
Stock issued during period shares new issues 6,600,000      
Price per share $ 10.20      
Transaction costs $ 4,859,330      
Cash underwriting fees 1,320,000      
Non-cash underwriting fees 2,922,480      
Other offering costs $ 616,850      
IPO [Member] | Sponsor [Member]        
Price per share $ 10.00      
IPO [Member] | Common Stock [Member]        
Proceeds from initial public offering, costs $ 66,000,000      
IPO [Member] | Underwriter [Member]        
Stock issued during period shares new issues 297,000      
Over-Allotment Option [Member] | Underwriter [Member]        
Stock issued during period shares new issues 600,000      
Price per share     $ 10.00  
Private Placement [Member]        
Stock issued during period shares new issues     394,000  
Proceeds from initial public offering, costs $ 67,320,000      
Price per share $ 10.00      
Private Placement [Member] | Sponsor [Member]        
Stock issued during period shares new issues 394,000      
Price per share $ 10.00      
Proceeds from private placement $ 3,940,000      
Public Shareholders [Member]        
Price per share $ 10.00      
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Gross proceeds $ 66,000,000  
Proceeds allocated to public rights (1,056,000)  
Offering costs allocated ordinary shares subject to redemption (4,755,805)  
Remeasurement of ordinary shares subject to redemption 7,624,825  
Ordinary shares subject to possible redemption $ 67,813,020
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details) - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Net income (loss) $ (10,113) $ 380,811  
Basic and diluted weighted average shares outstanding 1,725,000 1,865,478  
Basic and diluted net income per share $ (0.01) $ 0.12  
Net income (loss) $ (10,113) $ 380,811  
Ordinary Shares Subject To Redemption [Member]      
Net income (loss)   $ 159,314 $ (10,113)
Basic and diluted weighted average shares outstanding   1,341,758 1,725,000
Basic and diluted net income per share   $ 0.12 $ (0.01)
Net income (loss)   $ 159,314 $ (10,113)
Ordinary Shares Not Subject To Redemption [Member]      
Net income (loss)   $ 221,497  
Basic and diluted weighted average shares outstanding   1,865,478  
Basic and diluted net income per share   $ 0.12  
Net income (loss)   $ 221,497  
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]    
Cash equivalents $ 0 $ 0
Deferred offering costs 126,422
Unrecognized tax benefits 0 0
Amounts accrued for interest and penalties 0 0
Ordinary shares subject to possible redemption 67,813,020
FDIC insured amount 250,000  
Ordinary Shares Subject To Redemption [Member]    
Subsidiary, Sale of Stock [Line Items]    
Ordinary shares subject to possible redemption 67,813,020 0
IPO [Member]    
Subsidiary, Sale of Stock [Line Items]    
Deferred offering costs $ 0 $ 126,422
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.1
INITIAL PUBLIC OFFERING (Details Narrative) - $ / shares
12 Months Ended
Dec. 31, 2022
Oct. 18, 2022
Dec. 20, 2021
Subsidiary, Sale of Stock [Line Items]      
Price per share     $ 12.00
IPO [Member]      
Subsidiary, Sale of Stock [Line Items]      
Sale of stock shares issued in transaction 6,600,000    
Price per share   $ 10.20  
Ordinary share conversion basis Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the holder to one share of ordinary shares    
Over-Allotment Option [Member] | Underwriter [Member]      
Subsidiary, Sale of Stock [Line Items]      
Sale of stock shares issued in transaction 600,000    
Price per share $ 10.00    
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
PRIVATE PLACEMENTS (Details Narrative) - Private Placement [Member]
12 Months Ended
Dec. 31, 2022
shares
Subsidiary, Sale of Stock [Line Items]  
Private sale of private placement units 394,000
Ordinary share conversion basis Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”).
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTIES (Details Narrative) - USD ($)
10 Months Ended 12 Months Ended
Nov. 28, 2022
Dec. 20, 2021
Mar. 24, 2021
Dec. 31, 2021
Dec. 31, 2022
Oct. 18, 2022
Mar. 17, 2021
Related Party Transaction [Line Items]              
Common stock, par value       $ 0.0001 $ 0.0001    
Common stock, shares outstanding       2,416,000 2,416,000    
Sale of stock price per share   $ 12.00          
Due to related parties, current       $ 130,687    
Administrative service expenses       0 21,666    
Repayments of related party debt       $ 130,687    
Share price         $ 10.00    
Working capital loans       0 $ 0    
Underwriter [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Ordinary shares forfeiture   225,000          
Sponsor [Member]              
Related Party Transaction [Line Items]              
Due to related parties, current       $ 130,687 0    
Sponsor fees         $ 10,000    
Sponsor [Member] | Maximum [Member] | Unsecured Promissory Note [Member]              
Related Party Transaction [Line Items]              
Aggregate principal amount             $ 300,000
Common Stock [Member]              
Related Party Transaction [Line Items]              
Ordinary shares exchanged in consideration for issuance   1,437,500          
Common stock, par value         $ 0.0001    
Issuance of ordinary shares to Sponsor, shares       1,725,000      
Shares issued price per share   $ 0.0001          
Common stock, shares outstanding       1,725,000 1,725,000    
Ordinary shares forfeiture 150,000            
Common Stock [Member] | Sponsor [Member]              
Related Party Transaction [Line Items]              
Issuance of ordinary shares to Sponsor, shares   287,500          
Common stock, shares outstanding   1,725,000          
Common Class A [Member]              
Related Party Transaction [Line Items]              
Common stock, authorized but unissued   150,000,000          
Common stock, par value   $ 0.0001          
Common Class B [Member]              
Related Party Transaction [Line Items]              
Common stock, authorized but unissued   10,000,000          
Issuance of ordinary shares to Sponsor, shares   1,437,500          
Sponsor [Member]              
Related Party Transaction [Line Items]              
Ordinary shares exchanged in consideration for issuance     1,437,500        
Sale of stock price per share           $ 10.00  
Sponsor [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Sale of stock price per share           $ 10.00  
Sponsor [Member] | To Be Paid Later [Member]              
Related Party Transaction [Line Items]              
Exchange amounts transaction     $ 25,000        
Working Capital Loan [Member] | Sponsor [Member] | Maximum [Member]              
Related Party Transaction [Line Items]              
Repayments of related party debt         $ 1,500,000    
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES (Details Narrative) - $ / shares
Nov. 28, 2022
Oct. 18, 2022
Underwriters [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock issued during period shares new issues   270,000
Number of shares granted   297,000
IPO [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock issued during period shares new issues   6,600,000
IPO [Member] | Underwriters [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock repurchased during period, shares   900,000
Aggregate underwriting discount   $ 0.20
Over-Allotment Option [Member] | Underwriters [Member]    
Subsidiary, Sale of Stock [Line Items]    
Stock issued during period shares option exercised 600,000  
Stock issued during period shares new issues   310,500
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.1
SHAREHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - $ / shares
10 Months Ended 12 Months Ended
Nov. 28, 2022
Oct. 18, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 20, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Preferred stock, shares authorized     1,000,000 1,000,000  
Preferred stock, par or stated value per share     $ 0.0001 $ 0.0001  
Preferred stock, shares issued     0 0  
Preferred stock, shares outstanding     0 0  
Common stock, stock authorized     150,000,000 150,000,000  
Common stock, par value     $ 0.0001 $ 0.0001  
Common stock, shares issued     2,416,000 2,416,000  
Common stock, shares outstanding     2,416,000 2,416,000  
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock, stock authorized       150,000,000  
Common stock, par value       $ 0.0001  
Common stock, shares issued     1,725,000 1,725,000  
Common stock, shares outstanding     1,725,000 1,725,000  
Common stock shares not subject to forfeiture 150,000        
Outstanding percentage       19.00%  
Common Stock [Member] | Sponsor [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock, shares outstanding         1,725,000
Common Stock [Member] | Over-Allotment Option [Member] | Underwriter [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock shares not subject to forfeiture   150,000      
Common Stock [Member] | IPO [Member] | Sponsor [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Percentage of issued and outstanding shares     19.00% 19.00%  
Common Stock [Member] | Private Placement [Member] | Sponsor [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Percentage of issued and outstanding shares     23.00% 23.00%  
Common Stock [Member] | Maximum [Member] | Over-Allotment Option [Member] | Underwriter [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common stock shares not subject to forfeiture     225,000 225,000  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities held in the Trust Account $ 67,813,020
XML 39 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001851484 2022-01-01 2022-12-31 0001851484 TENKU:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightEntitlingHolderToReceiveTwotenthsOfOrdinaryShareMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesParValue0.0001PerShareMember 2022-01-01 2022-12-31 0001851484 TENKU:RightsEachRightEntitlingHolderToReceiveTwotenthsOfOneOrdinaryShareMember 2022-01-01 2022-12-31 0001851484 2022-06-30 0001851484 2023-04-17 0001851484 2022-12-31 0001851484 2021-12-31 0001851484 2021-03-01 2021-12-31 0001851484 us-gaap:CommonStockMember 2021-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001851484 TENKU:ShareholderReceivableMember 2021-12-31 0001851484 us-gaap:RetainedEarningsMember 2021-12-31 0001851484 us-gaap:CommonStockMember 2021-02-28 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 0001851484 TENKU:ShareholderReceivableMember 2021-02-28 0001851484 us-gaap:RetainedEarningsMember 2021-02-28 0001851484 2021-02-28 0001851484 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001851484 TENKU:ShareholderReceivableMember 2022-01-01 2022-12-31 0001851484 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001851484 us-gaap:CommonStockMember 2021-03-01 2021-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2021-03-01 2021-12-31 0001851484 TENKU:ShareholderReceivableMember 2021-03-01 2021-12-31 0001851484 us-gaap:RetainedEarningsMember 2021-03-01 2021-12-31 0001851484 us-gaap:CommonStockMember 2022-12-31 0001851484 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001851484 TENKU:ShareholderReceivableMember 2022-12-31 0001851484 us-gaap:RetainedEarningsMember 2022-12-31 0001851484 us-gaap:IPOMember 2022-10-17 2022-10-18 0001851484 TENKU:UnderwriterMember us-gaap:OverAllotmentOptionMember 2022-10-17 2022-10-18 0001851484 us-gaap:CommonStockMember us-gaap:IPOMember 2022-10-17 2022-10-18 0001851484 TENKU:SponsorMember us-gaap:PrivatePlacementMember 2022-10-17 2022-10-18 0001851484 TENKU:SponsorMember us-gaap:PrivatePlacementMember 2022-10-18 0001851484 TENKU:UnderwriterMember us-gaap:IPOMember 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember 2022-10-17 2022-10-18 0001851484 us-gaap:IPOMember 2022-10-18 0001851484 2022-10-17 2022-10-18 0001851484 us-gaap:PrivatePlacementMember 2022-10-18 0001851484 TENKU:PublicShareholdersMember 2022-10-18 0001851484 srt:MinimumMember 2022-10-18 0001851484 srt:MaximumMember 2022-10-18 0001851484 TENKU:SponsorMember us-gaap:IPOMember 2022-10-18 0001851484 TENKU:SponsorMember 2022-10-18 0001851484 srt:MaximumMember TENKU:SponsorMember 2022-10-18 0001851484 us-gaap:IPOMember 2022-12-31 0001851484 us-gaap:IPOMember 2021-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2022-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2021-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesNotSubjectToRedemptionMember 2022-01-01 2022-12-31 0001851484 TENKU:OrdinarySharesSubjectToRedemptionMember 2021-01-01 2021-12-31 0001851484 us-gaap:IPOMember 2022-01-01 2022-12-31 0001851484 TENKU:UnderwriterMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001851484 TENKU:UnderwriterMember us-gaap:OverAllotmentOptionMember 2022-12-31 0001851484 us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember 2021-03-23 2021-03-24 0001851484 TENKU:ToBePaidLaterMember TENKU:SponsorMember 2021-03-23 2021-03-24 0001851484 us-gaap:CommonClassAMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonClassAMember 2021-12-20 0001851484 us-gaap:CommonClassBMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2021-12-20 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember 2021-12-19 2021-12-20 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember 2021-12-20 0001851484 srt:MaximumMember TENKU:UnderwriterMember 2021-12-19 2021-12-20 0001851484 us-gaap:CommonStockMember 2022-11-27 2022-11-28 0001851484 2021-12-20 0001851484 srt:MaximumMember TENKU:UnsecuredPromissoryNoteMember TENKU:SponsorMember 2021-03-17 0001851484 TENKU:SponsorMember 2022-12-31 0001851484 TENKU:SponsorMember 2021-12-31 0001851484 TENKU:SponsorMember 2022-01-01 2022-12-31 0001851484 srt:MaximumMember TENKU:WorkingCapitalLoanMember TENKU:SponsorMember 2022-01-01 2022-12-31 0001851484 TENKU:UnderwritersMember us-gaap:IPOMember 2022-10-17 2022-10-18 0001851484 TENKU:UnderwritersMember us-gaap:OverAllotmentOptionMember 2022-11-27 2022-11-28 0001851484 TENKU:UnderwritersMember us-gaap:IPOMember 2022-10-18 0001851484 TENKU:UnderwritersMember 2022-10-17 2022-10-18 0001851484 TENKU:UnderwritersMember us-gaap:OverAllotmentOptionMember 2022-10-17 2022-10-18 0001851484 srt:MaximumMember TENKU:UnderwriterMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2022-01-01 2022-12-31 0001851484 srt:MaximumMember TENKU:UnderwriterMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2021-03-01 2021-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:IPOMember 2021-03-01 2021-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2022-01-01 2022-12-31 0001851484 TENKU:SponsorMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2021-03-01 2021-12-31 0001851484 TENKU:UnderwriterMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2022-10-17 2022-10-18 0001851484 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001851484 us-gaap:FairValueInputsLevel1Member 2021-12-31 iso4217:USD shares iso4217:USD shares pure 0001851484 false FY 10-K true 2022-12-31 --12-31 2022 false 001-41534 TenX Keane Acquisition E9 420 Lexington Avenue Suite 2446 New York NY 10170 (347) 627-0058 Units, each consisting of one ordinary share, $0.0001 par value, and one right entitling the holder to receive two-tenths of an ordinary share TENKU NASDAQ Ordinary shares, par value $0.0001 per share TENK NASDAQ Rights, each right entitling the holder to receive two-tenths of one ordinary share TENKR NASDAQ No No Yes Yes Non-accelerated Filer true true false false true 0 8941000 688 Marcum LLP West Palm Beach, Florida 289175 88169 126422 377344 126422 67813020 68190364 126422 31836 5848 130687 31836 136535 6600000 10.27 67813020 0.0001 0.0001 1000000 1000000 0 0 0 0 0.0001 0.0001 150000000 150000000 2416000 2416000 2416000 2416000 6600000 6600000 242 173 242 173 24827 -25000 345266 -10113 345508 -10113 68190364 126422 138115 10113 -138115 -10113 493020 25906 518926 380811 -10113 1865478 1725000 0.12 -0.01 1341758 0.12 1725000 173 24827 -25000 -10113 -10113 25000 25000 394000 39 3939961 3940000 1056000 1056000 297000 30 2922450 2922480 343845 343845 -7599393 -25432 -7624825 380811 380811 2416000 242 345266 345508 1725000 173 24827 -25000 -10113 -10113 -10113 -10113 1725000 173 24827 -25000 -10113 -10113 380811 -10113 493020 88169 10113 126422 25988 -47968 67320000 -67320000 66000000 3335987 1320000 253157 25000 130687 67657143 289175 289175 7624825 126422 <p id="xdx_800_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zFaGg1Zz4xC1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_820_zYluEIX2iiAj">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TenX Keane Acquisition (the “Company”) was incorporated in the Cayman Islands on March 1, 2021. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is not limited to a particular industry or sector for purposes of consummating an Initial Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had not commenced any operations. All activity for the period from March 1, 2021 (inception) through December 31, 2022 relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below. The Company will not generate any operating revenues until after the completion an initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Proposed Public Offering. The Company has selected December 31 as its fiscal year end.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The registration statement for the Company’s Initial Public Offering (the “Registration Statement”) was declared effective on October 13, 2022. On October 18, 2022, the Company consummated the Initial Public Offering of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxbBitxpLT83" title="Stock issued during period, shares">6,600,000</span> units, including <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zGMenXQbnhS4" title="Stock issued during period, shares">600,000</span> additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option, (“Units” and, with respect to the common stock included in the Units being offered, the “Public Shares”), generating gross proceeds of $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8yOQtVOFX1j" title="Proceeds from initial public offering, costs">66,000,000</span>, which is described in Note 3.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the consummation of the Initial Public Offering and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zfOdc47QLAu7" title="Number of units issued">394,000</span> Units (the “Placement Units”), to the 10XYZ Holdings LP (the “Sponsor”) at a price of $<span id="xdx_903_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zpjEsP4YtkTg" title="Price per share">10.00</span> per Placement Unit, generating total proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zpVFFnesz8Ud" title="Proceeds from private placement">3,940,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of October 18, 2022, transaction costs amounted to $<span id="xdx_900_eus-gaap--PaymentsOfStockIssuanceCosts_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhacD0S0TZu8" title="Transaction costs">4,859,330</span> consisting of $<span id="xdx_908_eus-gaap--PaymentsForUnderwritingExpense_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zz13d1tJGCrh" title="Cash underwriting fees">1,320,000</span> of cash underwriting fees, non-cash underwriting fees of $<span id="xdx_904_ecustom--PaymentsForNonCashUnderwritingExpense_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z0hbf90mPvb2" title="Non-cash underwriting fees">2,922,480</span> represented by the fair value of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_z1IvmqABC7te" title="Stock issued during period shares new issues">297,000</span> shares issued to the underwriter and $<span id="xdx_90C_ecustom--OtherOfferingCosts_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zqmcBIsLJ433" title="Other offering costs">616,850</span> of other offering costs. These costs were charged to additional paid-in capital or accumulated deficit to the extent additional paid-in capital is fully depleted upon completion of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following the closing of the Initial Public Offering on October 18, 2022, an amount of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBtRRqo0aILd" title="Proceeds from initial public offering, costs">67,320,000</span> ($<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zgkHeR2gb798" title="Price per share">10.20</span> per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement (as defined in Note 4) was placed in the Trust Account. The funds held in the Trust Account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the Trust Account, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least <span id="xdx_904_ecustom--ConditionForFutureBusinessCombinationUseOfProceedsPercentage_dp_c20221017__20221018_zROozUbgaVzf" title="Condition for future business combination use of proceeds percentage">80</span>% of the assets held in the Trust Account (as defined below) (excluding the taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the post-Business Combination company owns or acquires <span id="xdx_907_ecustom--ConditionForFutureBusinessCombinationThresholdPercentageOwnership_dp_c20221017__20221018_zP2jPDGAFONh" title="Condition for future business combination threshold percentage ownership">50</span>% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the Proposed Public Offering, management has agreed that $<span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zZR9Ce3GjAkc" title="Price per share">10.00</span> per Unit sold in the Proposed Public Offering, including proceeds of the sale of the Private Placement Units, will be held in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer in connection with the Business Combination. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $<span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicShareholdersMember_z0WGwG2CsKAc" title="Price per share">10.00</span> per Public Share, plus any pro rata interest then in the Trust Account, net of taxes payable).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of the Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain amendments to the Company’s amended and restated certificate of incorporation (the “Certificate of Incorporation”). In accordance with the rules of the U.S. Securities and Exchange Commission (the “SEC”) and its guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require common stock subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding instruments (i.e., rights), the initial carrying value of ordinary shares classified as temporary equity will be the allocated proceeds determined in accordance with ASC 470-20. The ordinary shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period. The Company has elected to immediate fair value recognition. The accretion will be treated as a deemed dividend (i.e., a reduction to retained earnings, or in absence of retained earnings, additional paid-in capital). While redemptions cannot cause the Company’s net tangible assets to fall below $<span id="xdx_90B_ecustom--NetTangibleAssetsUponRedemptionOfBusinessCombinations_iI_c20221018__srt--RangeAxis__srt--MinimumMember_zV3OSMEwcLWj" title="Net tangible assets upon redemption of business combinations">5,000,001</span>, the Public Shares are redeemable and will be classified as such on the balance sheet until such date that a redemption event takes place.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will not redeem Public Shares in an amount that would cause its net tangible assets to be less than $<span id="xdx_908_ecustom--NetTangibleAssetsUponRedemptionOfBusinessCombinations_iI_c20221018__srt--RangeAxis__srt--MaximumMember_z7H31Fpdasw9" title="Net tangible assets upon redemption of business combinations">5,000,001</span> (so that it does not then become subject to the SEC’s “penny stock” rules) or any greater net tangible asset or cash requirement that may be contained in the agreement relating to the Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed with a Business Combination only if the Company receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company, or such other vote as required by law or stock exchange rule. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (the “SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Proposed Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of <span id="xdx_906_ecustom--RedemptionLimitPercentageWithoutPriorWrittenConsent_dp_c20221017__20221018_z8TiPD9mtXsd" title="Redemption limit percentage without prior written consent">15</span>% of the Public Shares without the Company’s prior written consent.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem <span id="xdx_905_ecustom--PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_dp_c20221017__20221018_ztvh1vdp4Yfk" title="Percentage obligation to redeem public shares if entity does not complete business combination">100</span>% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company will have until 9 months (or 18 months if the Company extends the period) from the closing of the Public Offering to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem <span id="xdx_90C_ecustom--PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination_dp_c20221017__20221018_ze3P7izZyN63" title="Percentage obligation to redeem public shares if entity does not complete business combination">100</span>% of the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to us to pay our taxes, if any (less up to $<span id="xdx_90B_ecustom--MaximumAllowedDissolutionExpenses_c20221017__20221018_z4fo9Feriuaj" title="Maximum allowed dissolution expenses">100,000</span> of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Public Offering price per Unit ($<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zqdNTzOXxJuk" title="Price per share">10.00</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zZOmGnYZ2kO1" title="Price per share">10.00</span> per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $<span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20221018__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zwRU6iG77Cxg" title="Price per share">10.00</span> per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Proposed Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going Concern Consideration</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, <i>“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,”</i> management believes that the funds which the Company has available following the completion of the Initial Public Offering will enable it to sustain operations for a period of at least one-year from the issuance date of this financial statement. However, management has determined that the combination period is less than one year from the date of the issuance of the financial statements. There is no assurance that the Company’s plans to consummate a business combination will be successful within the combination period. As a result, there is substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued or are available to be issued. The financial statements do not include any adjustments that might result from the outcome of the uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks and Uncertainties</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, close of the Proposed Public Offering and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6600000 600000 66000000 394000 10.00 3940000 4859330 1320000 2922480 297000 616850 67320000 10.20 0.80 0.50 10.00 10.00 5000001 5000001 0.15 1 1 100000 10.00 10.00 10.00 <p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zqkzTcSKFh2a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 — <span id="xdx_82D_zwetzbBNlHTh">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zf8iEnigymr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zQ1RroJNlPQ1">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zJ4m3mmlkGM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zUVUl2KOqlmb">Emerging Growth Company</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zjpucr8H2dNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zIbKJO2LsTwc">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjuhyNsZYyIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zVOFlrVClOI4">Cash and cash equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zQKetoPOAa9g" title="Cash equivalents"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_zkxwKx4QWCT4" title="Cash equivalents">no</span></span> cash equivalents at December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/><p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_ziE8UFNIuO22" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zh9GpuLVTRe9">Deferred Offering Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. As of December 31, 2022 and 2021 the Company had deferred offering costs of $<span id="xdx_90B_eus-gaap--DeferredOfferingCosts_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2ohHHEj3Bv" title="Deferred offering costs">0</span>, and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zIyNRoQ1dDU3" title="Deferred offering costs">126,422</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zhxR7J0KEus9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zHU8Yqk07MF">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zfhz62gsSbKf" title="Unrecognized tax benefits"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zq6Cb15wyG56" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20221231_zlXM1vvSaft4" title="Amounts accrued for interest and penalties"><span title="Unrecognized tax benefits"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20211231_zWmFLmt2dQCj" title="Amounts accrued for interest and penalties">no</span></span></span> amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zi1ysqFpfD1k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_z1JnXrdcCz16">Ordinary Shares Subject to Possible Redemption</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480, “<i>Distinguishing Liabilities from Equity</i>.” Shares of the common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of the common stock (including shares of the common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the issuer’s control) are classified as temporary equity. At all other times, shares of the common stock are classified as stockholders’ equity. The ordinary features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, the ordinary shares subject to possible redemption in the amount of $<span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zcgncBnrl367" title="Ordinary shares subject to possible redemption">67,813,020</span> and $<span id="xdx_90E_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zhB7OmsNpf4a" title="Ordinary shares subject to possible redemption">0</span>, respectively, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SharesSubjectToMandatoryRedemptionDisclosureTextBlock_zBwtqfzelnT6" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z7x0o7zOSqBa" style="display: none">SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20221231_zHL8nwtaIcc7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsAmount_iI_zgfsKgEHqgjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ProceedsAllocatedToPublicRights_zVSDMTyKytGe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds allocated to public rights</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,056,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--OfferingCostsAllocatedOrdinarySharesSubjectToRedemption_iI_zrQeFfNT707c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Offering costs allocated ordinary shares subject to redemption</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,755,805</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--TemporaryEquityAccruedInterestInTrust_iI_z6mkDqEE3Tt2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Remeasurement of ordinary shares subject to redemption</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,624,825</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iTI_zvyMeVsKPON4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,813,020</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zxeriNiQhNqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zlbdbu5VXQEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_za8DRSW5H6wb">Net income (loss) per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zEeQG2ReWM9f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyYrLfLz5ne6" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zsalnLyXMCG7" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNotSubjectToRedemptionMember_zUvDhvvBfRh" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ended December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_mtNILz9wN_zyBEh7SIb3Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation of net income</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159,314</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,497</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zUzRGysNgY42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,341,758</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,865,478</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zuP4M3m3AHT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49D_20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zNy4Jl1bSX45" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Year</span> Ended December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zmabB5vcmdc2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zmFMu9C8RiOj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,725,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_zNYu4xLlaew8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.01</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8A8_z1sazMgFr2Sg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_zpXMeF5UpKVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zpkaX2yhuqC6">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zF31wPBF2itj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zt1SiKZwxmuj">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zz3NNRoMPnP" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z5mWerRdTqRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zkb15AzWVfj6">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 Inputs: Significant inputs into the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any recurring Level 2 assets or liabilities, see Note 8 for Level 3 assets and liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlcMyQLXLkC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z1odaZ5LnPG3">Recent Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “<i>Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>,” which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_851_zBYpIZqudYp9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zf8iEnigymr1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zQ1RroJNlPQ1">Basis of Presentation</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zJ4m3mmlkGM9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zUVUl2KOqlmb">Emerging Growth Company</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, as amended (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--UseOfEstimates_zjpucr8H2dNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_863_zIbKJO2LsTwc">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zjuhyNsZYyIc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zVOFlrVClOI4">Cash and cash equivalents</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had <span id="xdx_904_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20221231_zQKetoPOAa9g" title="Cash equivalents"><span id="xdx_906_eus-gaap--CashEquivalentsAtCarryingValue_iI_do_c20211231_zkxwKx4QWCT4" title="Cash equivalents">no</span></span> cash equivalents at December 31, 2022 and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"/> 0 0 <p id="xdx_841_eus-gaap--DeferredChargesPolicyTextBlock_ziE8UFNIuO22" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zh9GpuLVTRe9">Deferred Offering Costs</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred offering costs consist of costs incurred in connection with preparation for the Initial Public Offering. These costs, together with the underwriting discounts and commissions, were charged to additional paid in capital upon completion of the Initial Public Offering. As of December 31, 2022 and 2021 the Company had deferred offering costs of $<span id="xdx_90B_eus-gaap--DeferredOfferingCosts_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2ohHHEj3Bv" title="Deferred offering costs">0</span>, and $<span id="xdx_90A_eus-gaap--DeferredOfferingCosts_iI_c20211231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zIyNRoQ1dDU3" title="Deferred offering costs">126,422</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 126422 <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zhxR7J0KEus9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zHU8Yqk07MF">Income Taxes</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the asset and liability method of accounting for income taxes under ASC 740, “<i>Income Taxes</i>.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20221231_zfhz62gsSbKf" title="Unrecognized tax benefits"><span id="xdx_901_eus-gaap--UnrecognizedTaxBenefits_iI_do_c20211231_zq6Cb15wyG56" title="Unrecognized tax benefits">no</span></span> unrecognized tax benefits and <span id="xdx_900_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20221231_zlXM1vvSaft4" title="Amounts accrued for interest and penalties"><span title="Unrecognized tax benefits"><span id="xdx_90D_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_do_c20211231_zWmFLmt2dQCj" title="Amounts accrued for interest and penalties">no</span></span></span> amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0 0 0 0 <p id="xdx_845_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_zi1ysqFpfD1k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_z1JnXrdcCz16">Ordinary Shares Subject to Possible Redemption</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC 480, “<i>Distinguishing Liabilities from Equity</i>.” Shares of the common stock subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable shares of the common stock (including shares of the common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the issuer’s control) are classified as temporary equity. At all other times, shares of the common stock are classified as stockholders’ equity. The ordinary features certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, the ordinary shares subject to possible redemption in the amount of $<span id="xdx_90F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zcgncBnrl367" title="Ordinary shares subject to possible redemption">67,813,020</span> and $<span id="xdx_90E_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zhB7OmsNpf4a" title="Ordinary shares subject to possible redemption">0</span>, respectively, are presented as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--SharesSubjectToMandatoryRedemptionDisclosureTextBlock_zBwtqfzelnT6" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z7x0o7zOSqBa" style="display: none">SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20221231_zHL8nwtaIcc7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsAmount_iI_zgfsKgEHqgjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ProceedsAllocatedToPublicRights_zVSDMTyKytGe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds allocated to public rights</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,056,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--OfferingCostsAllocatedOrdinarySharesSubjectToRedemption_iI_zrQeFfNT707c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Offering costs allocated ordinary shares subject to redemption</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,755,805</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--TemporaryEquityAccruedInterestInTrust_iI_z6mkDqEE3Tt2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Remeasurement of ordinary shares subject to redemption</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,624,825</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iTI_zvyMeVsKPON4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,813,020</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A5_zxeriNiQhNqd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 67813020 0 <p id="xdx_897_eus-gaap--SharesSubjectToMandatoryRedemptionDisclosureTextBlock_zBwtqfzelnT6" style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, ordinary shares subject to possible redemption reflected on the balance sheet is reconciled on the following table:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_z7x0o7zOSqBa" style="display: none">SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_494_20221231_zHL8nwtaIcc7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsAmount_iI_zgfsKgEHqgjd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Gross proceeds</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">66,000,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_ecustom--ProceedsAllocatedToPublicRights_zVSDMTyKytGe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds allocated to public rights</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,056,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--OfferingCostsAllocatedOrdinarySharesSubjectToRedemption_iI_zrQeFfNT707c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Offering costs allocated ordinary shares subject to redemption</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,755,805</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_ecustom--TemporaryEquityAccruedInterestInTrust_iI_z6mkDqEE3Tt2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">Remeasurement of ordinary shares subject to redemption</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,624,825</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iTI_zvyMeVsKPON4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Ordinary shares subject to possible redemption</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,813,020</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 66000000 -1056000 -4755805 7624825 67813020 <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_zlbdbu5VXQEh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_866_za8DRSW5H6wb">Net income (loss) per share</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per share of ordinary shares is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per ordinary share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The calculation of diluted income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the Private Placement since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2022 and 2021, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the period presented.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zEeQG2ReWM9f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyYrLfLz5ne6" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zsalnLyXMCG7" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNotSubjectToRedemptionMember_zUvDhvvBfRh" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ended December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_mtNILz9wN_zyBEh7SIb3Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation of net income</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159,314</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,497</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zUzRGysNgY42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,341,758</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,865,478</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zuP4M3m3AHT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49D_20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zNy4Jl1bSX45" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Year</span> Ended December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zmabB5vcmdc2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zmFMu9C8RiOj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,725,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_zNYu4xLlaew8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.01</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8A8_z1sazMgFr2Sg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p id="xdx_890_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zEeQG2ReWM9f" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table reflects the calculation of basic and diluted net income (loss) per ordinary share (in dollars, except per share amounts):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zyYrLfLz5ne6" style="display: none">SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zsalnLyXMCG7" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_492_20220101__20221231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesNotSubjectToRedemptionMember_zUvDhvvBfRh" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">For the Year</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Ended December 31, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Ordinary Shares</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Not Subject to</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif">Redemption</span></p></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Numerator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_404_eus-gaap--NetIncomeLoss_iT_mtNILz9wN_zyBEh7SIb3Ci" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Allocation of net income</span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">159,314</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">221,497</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif">Denominator:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_402_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zUzRGysNgY42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted weighted average shares outstanding</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,341,758</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,865,478</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eus-gaap--EarningsPerShareBasic_zuP4M3m3AHT3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted net income per share</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">0.12</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_49D_20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToRedemptionMember_zNy4Jl1bSX45" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Year</span> Ended December 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary Shares</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--NetIncomeLoss_zmabB5vcmdc2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 78%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,113</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_zmFMu9C8RiOj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted weighted average shares outstanding</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,725,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--EarningsPerShareBasic_zNYu4xLlaew8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic and diluted net income per share</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(0.01</span></td><td style="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 159314 221497 1341758 1865478 0.12 0.12 -10113 1725000 -0.01 <p id="xdx_84A_eus-gaap--DerivativesPolicyTextBlock_zpXMeF5UpKVc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zpkaX2yhuqC6">Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zF31wPBF2itj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_865_zt1SiKZwxmuj">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_c20221231_zz3NNRoMPnP" title="FDIC insured amount">250,000</span>. The Company has not experienced losses on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 <p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z5mWerRdTqRf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86F_zkb15AzWVfj6">Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines fair value based on assumptions that market participants would use in pricing an asset or liability in the principal or most advantageous market. When considering market participant assumptions in fair value measurements, the following fair value hierarchy distinguishes between observable and unobservable inputs, which are categorized in one of the following levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 Inputs: Unadjusted quoted prices for identical assets or instruments in active markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 Inputs: Quoted prices for similar instruments in active markets and quoted prices for identical or similar instruments in markets that are not active and model derived valuations whose inputs are observable or whose significant value drivers are observable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 Inputs: Significant inputs into the valuation model are unobservable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any recurring Level 2 assets or liabilities, see Note 8 for Level 3 assets and liabilities. The carrying value of the Company’s financial instruments including its cash and accrued liabilities approximate their fair values principally because of their short-term nature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zlcMyQLXLkC9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_z1odaZ5LnPG3">Recent Accounting Standards</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued Accounting Standards Update (“ASU”) No. 2020-06, “<i>Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)</i>,” which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for the derivative scope exception, and it simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for the Company on January 1, 2022. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.</span></p> <p id="xdx_807_ecustom--InitialPublicOfferingTextBlock_zAmL6zfEAFYa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — <span id="xdx_82F_zbuIYk8YC8a">INITIAL PUBLIC OFFERING</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the Initial Public Offering, the Company sold <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zXNt4hVpJAL4" title="Sale of stock shares issued in transaction">6,600,000</span> Units, including <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zsaUKA2cX9y7" title="Sale of stock shares issued in transaction">600,000 </span>additional units issued pursuant to the partial exercise by the underwriter of its over-allotment option at a price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zJRaheYoblWl" title="Price per share">10.00</span> per Unit. <span id="xdx_90E_eus-gaap--CommonStockConversionBasis_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmNcfK5rDw8l" title="Ordinary share conversion basis">Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the holder to one share of ordinary shares</span> (see Note 7).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 6600000 600000 10.00 Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). Five Public Rights will entitle the holder to one share of ordinary shares <p id="xdx_801_ecustom--PrivatePlacementTextBlock_zZ2hF1kAegG" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 — <span id="xdx_82A_zArZ1eXHfZK1">PRIVATE PLACEMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z0KTYsbCh4Pe" title="Private sale of private placement units">394,000</span> Private Placement Units.<span id="xdx_90E_eus-gaap--CommonStockConversionBasis_c20220101__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zbpfup4qkX17" title="Ordinary share conversion basis"> Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”).</span> The proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). The Private Placement Units and Private Rights (including the ordinary shares issuable upon exercise of the Private Rights) will not be transferable, assignable or salable until 30 days after the completion of an Initial Business Combination, subject to certain exceptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 394000 Each Unit consists of one share of ordinary shares and one right to receive two-tenths (2/10) of one Ordinary Share upon the consummation of the Company’s initial business combination one right (“Public Right”). <p id="xdx_80C_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zj7BJF51TVm7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 — <span id="xdx_827_zmCxd1UMWs0f">RELATED PARTIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder Shares</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 24, 2021, the Sponsor received <span id="xdx_90A_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20210323__20210324__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z4rUvH8dh92f" title="Sponsor received ordinary shares">1,437,500</span> of the Company’s ordinary shares (the “Founder Shares”) in exchange for $<span id="xdx_904_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_c20210323__20210324__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember__us-gaap--AwardTypeAxis__custom--ToBePaidLaterMember_zSzyC4e4DIjg" title="Exchange amounts transaction">25,000</span> to be paid at a later date. On December 20, 2021, the board of directors of the Company and our sponsor, as sole shareholder of the Company, approved, through a special resolution, the following share capital changes:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the authorized but unissued <span id="xdx_90F_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zexeo9VcT1Ok" title="Common stock, authorized but unissued">150,000,000</span> Class A ordinary shares were cancelled and re-designated as ordinary shares of $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z2frElBw8gI7" title="Common stock, par value">0.0001</span> par value each;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zYd5T1NzN8x4" title="Stock issued during period shares new issues">1,437,500</span> Class B ordinary shares in issue were exchanged in consideration for the issuance of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20211219__20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJf6nicy5Qv4" title="Ordinary shares exchanged in consideration for issuance">1,437,500</span> ordinary shares of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXnvu4Ze6Xzg" title="Shares issued price per share">0.0001</span> par value each; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon completion of the above steps, the authorized but unissued <span id="xdx_90E_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_pid_c20211219__20211220__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z86yPjBAaZ46" title="Common stock, authorized but unissued">10,000,000 </span>Class B ordinary shares were cancelled.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 20, 2021, subsequent to the above share exchange the Company issued an additional <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20211219__20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_z5fcaFc3Z045" title="Ordinary shares issued">287,500</span> ordinary shares to our Sponsor for no additional consideration, resulting in our Sponsor holding an aggregate of <span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211220__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zLSSoCnfsbn6" title="Common stock, shares outstanding">1,725,000</span> ordinary shares (the founder shares). The issuance was considered as a bonus share issuance, in substance a recapitalization transaction, which was recorded and presented retroactively. The founder shares include an aggregate of up to <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20211219__20211220__us-gaap--SubsidiarySaleOfStockAxis__custom--UnderwriterMember__srt--RangeAxis__srt--MaximumMember_zUIZ70yyfuNj" title="Common stock shares subject to forfeiture">225,000</span> ordinary shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part. On October 18, 2022, the underwriter partially exercised the over-allotment and as such, as of November 28, 2022, <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20221127__20221128__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxAgmYjSo83j" title="Ordinary shares forfeiture">150,000</span> ordinary shares are not subject to forfeiture.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the ordinary shares equals or exceeds $<span id="xdx_90A_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20211220_zEQsB3F8MHuk" title="Sale of stock price per share">12.00</span> per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their shares of ordinary shares for cash, securities or other property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Promissory Note — Related Party</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2021, the Sponsor issued an unsecured promissory note (the “Pre-IPO Note”) to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20210317__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromissoryNoteMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zAIVIw9oVF5g" title="Aggregate principal amount">300,000</span>. The Promissory Note is non-interest bearing and payable on the earlier of (i) September 30, 2022 or (ii) the consummation of the Proposed Public Offering. As of December 31, 2022 and December 31, 2021, there were no amounts outstanding under the Promissory Note. After expiration of the Promissory Note, the Sponsor issued a new unsecured promissory note to the Company (the “Post-IPO Promissory Note”) on April 14, 2023. The Post-IPO Promissory Note is non-interest bearing and payable on the earlier of (i) April 14, 2024 or (ii) <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the date of consummation of the Company’s initial business combination or liquidation (such earlier date, the “<b>Maturity Date</b>”).</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advances from Related Party</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Sponsor paid certain formation and operating costs on behalf of the Company. These advances are due on demand and non-interest bearing. As of December 31, 2022 and 2021, the amount due to the Sponsor was $<span id="xdx_90A_eus-gaap--DueToRelatedPartiesCurrent_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zEDOD1IvhM04" title="Due to related parties, current">0 </span>and $<span id="xdx_900_eus-gaap--DueToRelatedPartiesCurrent_iI_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zXE2hJ34bRQa" title="Due to related parties, current">130,687</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative Services Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing on the date the Units are first listed on the Nasdaq, the Company has agreed to pay the Sponsor a total of $<span id="xdx_909_eus-gaap--SponsorFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zhaqYkMqL0a3" title="Sponsor fees">10,000</span> per month for office space, utilities and secretarial and administrative support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. The Company has incurred expense of $<span id="xdx_90E_eus-gaap--OtherGeneralAndAdministrativeExpense_c20220101__20221231_zTud1vyd410c" title="Administrative service expenses">21,666</span> for the year ended December 31, 2022. <span id="xdx_90B_eus-gaap--OtherGeneralAndAdministrativeExpense_do_c20210301__20211231_zc7GDcxOpBJg" title="Administrative service expenses">No</span> expense was incurred in 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Related Party Loans</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $<span id="xdx_904_eus-gaap--RepaymentsOfRelatedPartyDebt_c20220101__20221231__us-gaap--RelatedPartyTransactionAxis__custom--WorkingCapitalLoanMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zjZHP1hrDHxd" title="Repayments of related party debt">1,500,000 </span>of the notes may be converted into units, at the price of $<span id="xdx_90A_eus-gaap--SharePrice_iI_pid_c20221231_zaiC3ei4Bcr9" title="Share price">10.00</span> per unit at the option of the lender. Such units would be identical to the Private Placement Units In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. As of December 31, 2022 and 2021, there were <span id="xdx_904_ecustom--WorkingCapitalLoans_iI_do_c20221231_zcYUqewmXZgj" title="Working capital loans"><span id="xdx_90C_ecustom--WorkingCapitalLoans_iI_do_c20211231_zVsASyoNkE3e" title="Working capital loans">no</span></span> amounts outstanding under the Working Capital Loans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1437500 25000 150000000 0.0001 1437500 1437500 0.0001 10000000 287500 1725000 225000 150000 12.00 300000 0 130687 10000 21666 0 1500000 10.00 0 0 <p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zOyCknEMYFp6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 — <span id="xdx_820_zQ6zYbeh07r1">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration Rights</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of the Founder Shares, Private Placement Units and Units that may be issued upon conversion of Working Capital Loans (and any shares of ordinary shares issuable upon the exercise of the Private Placement Right) will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriting Agreement</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to <span id="xdx_900_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zNGRaheVU108" title="Stock repurchased during period, shares">900,000</span> additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriter partially exercised the over-allotment in the amount of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20221127__20221128__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zg1viF7H47dj" title="Stock issued during period shares option exercised">600,000</span> Units during the option period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The underwriters are entitled to a cash underwriting discount of $<span id="xdx_905_ecustom--UnderwritingCommitmentsPerShare_iI_c20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z7swF1vBPJMd" title="Aggregate underwriting discount">0.20</span> per Unit payable upon the closing of the Initial Public Offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The underwriters are also entitled to <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zAzoVpRbG5Eh" title="Stock issued during period shares new issues">270,000</span> ordinary shares (<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20221017__20221018__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zCb92atxfaZb" title="Stock issued during period shares new issues">310,500</span> if the over-allotment option is exercised in full) as part of its underwriting fee. Due to the partial exercise, the shares granted at October 18, 2022 were <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20221017__20221018__srt--TitleOfIndividualAxis__custom--UnderwritersMember_ze3ScNKxRwX8" title="Number of shares granted">297,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 900000 600000 0.20 270000 310500 297000 <p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zKG9tEP80ytg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — <span id="xdx_825_zaR1rflNPS78">SHAREHOLDERS’ EQUITY (DEFICIT)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Preferred Shares</i></b> — The Company is authorized to issue <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zqfNyAVOSOml" title="Preferred stock, shares authorized">1,000,000</span> preferred shares with a par value of $<span id="xdx_907_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_zsuthigjZVF1" title="Preferred stock, par or stated value per share">0.0001</span> per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2022 and 2021, there were <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20221231_zAGa4E4NDOk8" title="Preferred stock, shares issued"><span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_pid_do_c20211231_z4UrhLlA6me5" title="Preferred stock, shares issued"><span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20221231_zz47jRAlnNck" title="Preferred stock, shares outstanding"><span id="xdx_902_eus-gaap--PreferredStockSharesOutstanding_iI_pid_do_c20211231_zYP39XCi6S7j" title="Preferred stock, shares outstanding">no</span></span></span></span> shares of preferred shares issued or outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary Shares</i></b> — The Company is authorized to issue <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zQ5xFvVMHfZ4" title="Common stock, stock authorized">150,000,000</span> ordinary shares with a par value of $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z581Hrj2UNp" title="Common stock, par value">0.0001</span> per share. Holders of ordinary shares are entitled to one vote for each share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 and 2021, there were <span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z3XieBELXlwl" title="Common stock, shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn0662T5A1r8" title="Common stock, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zX9pJGG3d2vk" title="Common stock, shares outstanding"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvxeWBC9j78k" title="Common stock, shares outstanding">1,725,000</span></span></span></span> ordinary shares issued and outstanding, of which an aggregate of up to <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zNuq5pYZRJu7" title="Common stock shares subject to forfeiture"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20210301__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--RangeAxis__srt--MaximumMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zPOdlymToqmd" title="Common stock shares subject to forfeiture">225,000</span></span> ordinary shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part so that the number of Founder Shares will equal <span id="xdx_908_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmIky22JOL3" title="Percentage of issued and outstanding shares"><span id="xdx_90A_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20210301__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zxpmSPEbOPjb" title="Percentage of issued and outstanding shares">19</span></span>% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering (excluding private placement shares) or approximately <span id="xdx_901_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zoPp3T6S1ira" title="Percentage of issued and outstanding shares"><span id="xdx_903_ecustom--PercentageOfIssuedAndOutstandingShares_pid_dp_uPure_c20210301__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrDmgYBAIgO4" title="Percentage of issued and outstanding shares">23.0</span></span>% (including private placement shares). The underwriter partially exercised the over-allotment and as such <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pid_c20221017__20221018__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__srt--TitleOfIndividualAxis__custom--UnderwriterMember_zW8E7QQnel1h" title="Common stock shares not subject to forfeiture">150,000</span> ordinary shares are not subject to forfeiture as of October 18, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only holders of the founder shares will have the right to vote on the election of directors prior to the Business Combination. Holders of ordinary shares and holders of founder shares will vote together as a single class on all matters submitted to a vote of our shareholders except as otherwise required by law. In connection with our initial business combination, we may enter into a shareholders’ agreement or other arrangements with the shareholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the case that additional shares of ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Proposed Public Offering and relate to the closing of a Business Combination, the ratio at which founder shares will be adjusted (unless the holders of a majority of the then-outstanding shares of founder shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of founder shares will equal, in the aggregate, <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zqySFyUHMG7d" title="Outstanding percentage">19</span>% of the sum of the total number of all shares of ordinary shares outstanding upon the completion of Proposed Public Offering plus all shares of ordinary shares and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of ordinary shares redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rights </i></b>- Except in cases where the Company is not the surviving company in a business combination, each holder of a right will automatically receive two-tenths (2/10) of one ordinary share upon consummation of the initial business combination. The Company will not issue fractional shares in connection with an exchange of rights. Fractional shares will either be rounded down to the nearest whole share or otherwise addressed in accordance with the applicable provisions of Cayman law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1000000 0.0001 0 0 0 0 150000000 0.0001 1725000 1725000 1725000 1725000 225000 225000 0.19 0.19 0.230 0.230 150000 0.19 <p id="xdx_808_eus-gaap--FairValueDisclosuresTextBlock_zzAfR3cFUIhd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8. <span id="xdx_82E_zxxsMMMEoa25">FAIR VALUE MEASUREMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 96%; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.25in"> <tr style="vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.6in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3:</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zg0EmLTyfgBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z8to5KQ3XMda" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20221231_zn5duBmgkTjb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20211231_zgZCgqwU4ncd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">        </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6WSqaLaZuhj" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities held in the Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,813,020</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A4_z7U38JRfuHH8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89A_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zg0EmLTyfgBl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents information about the Company’s assets and liabilities that are measured at fair value at December 31, 2022 and 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_z8to5KQ3XMda" style="display: none">SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif">Description</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Level</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20221231_zn5duBmgkTjb" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, <br/> 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49D_20211231_zgZCgqwU4ncd" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">December 31, <br/> 2021</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="font-family: Times New Roman, Times, Serif">Assets:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">        </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure_iI_hus-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z6WSqaLaZuhj" style="vertical-align: bottom; background-color: White"> <td style="width: 54%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Marketable securities held in the Trust Account</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif">1</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">67,813,020</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0632">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 67813020 <p id="xdx_80C_eus-gaap--SubsequentEventsTextBlock_zan5KR6wHxdg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — <span id="xdx_823_zbqPrt8S3wqi">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</span></p> EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 41 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 88 168 1 false 26 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://tenxkeaneacquisition.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets Sheet http://tenxkeaneacquisition.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Parenthetical) Sheet http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations Sheet http://tenxkeaneacquisition.com/role/StatementsOfOperations Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Statements of Changes In Shareholders' Equity (Deficit) Sheet http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit Statements of Changes In Shareholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Statements of Cash Flows Sheet http://tenxkeaneacquisition.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Sheet http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - INITIAL PUBLIC OFFERING Sheet http://tenxkeaneacquisition.com/role/InitialPublicOffering INITIAL PUBLIC OFFERING Notes 9 false false R10.htm 00000010 - Disclosure - PRIVATE PLACEMENTS Sheet http://tenxkeaneacquisition.com/role/PrivatePlacements PRIVATE PLACEMENTS Notes 10 false false R11.htm 00000011 - Disclosure - RELATED PARTIES Sheet http://tenxkeaneacquisition.com/role/RelatedParties RELATED PARTIES Notes 11 false false R12.htm 00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://tenxkeaneacquisition.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 12 false false R13.htm 00000013 - Disclosure - SHAREHOLDERS??? EQUITY (DEFICIT) Sheet http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficit SHAREHOLDERS??? EQUITY (DEFICIT) Notes 13 false false R14.htm 00000014 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://tenxkeaneacquisition.com/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 14 false false R15.htm 00000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://tenxkeaneacquisition.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 00000018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://tenxkeaneacquisition.com/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://tenxkeaneacquisition.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative) Details http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern 19 false false R20.htm 00000020 - Disclosure - SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details) Sheet http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details) Details 20 false false R21.htm 00000021 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details) Sheet http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details) Details 21 false false R22.htm 00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables 22 false false R23.htm 00000023 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative INITIAL PUBLIC OFFERING (Details Narrative) Details http://tenxkeaneacquisition.com/role/InitialPublicOffering 23 false false R24.htm 00000024 - Disclosure - PRIVATE PLACEMENTS (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative PRIVATE PLACEMENTS (Details Narrative) Details http://tenxkeaneacquisition.com/role/PrivatePlacements 24 false false R25.htm 00000025 - Disclosure - RELATED PARTIES (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative RELATED PARTIES (Details Narrative) Details http://tenxkeaneacquisition.com/role/RelatedParties 25 false false R26.htm 00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://tenxkeaneacquisition.com/role/CommitmentsAndContingencies 26 false false R27.htm 00000027 - Disclosure - SHAREHOLDERS??? EQUITY (DEFICIT) (Details Narrative) Sheet http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative SHAREHOLDERS??? EQUITY (DEFICIT) (Details Narrative) Details http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficit 27 false false R28.htm 00000028 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details) Sheet http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details) Details 28 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 29, 5356, 6768 [dq-0547-EntityTaxIdentificationNumber-Missing] Submission type 10-K should have a non-empty value for EntityTaxIdentificationNumber in the Required Context. form10-k.htm form10-k.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm tenku-20221231.xsd tenku-20221231_cal.xml tenku-20221231_def.xml tenku-20221231_lab.xml tenku-20221231_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 46 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 257, "http://xbrl.sec.gov/dei/2022": 43 }, "contextCount": 88, "dts": { "calculationLink": { "local": [ "tenku-20221231_cal.xml" ] }, "definitionLink": { "local": [ "tenku-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "tenku-20221231_lab.xml" ] }, "presentationLink": { "local": [ "tenku-20221231_pre.xml" ] }, "schema": { "local": [ "tenku-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 273, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 46, "http://tenxkeaneacquisition.com/20221231": 10, "http://xbrl.sec.gov/dei/2022": 3, "total": 59 }, "keyCustom": 32, "keyStandard": 136, "memberCustom": 13, "memberStandard": 11, "nsprefix": "TENKU", "nsuri": "http://tenxkeaneacquisition.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://tenxkeaneacquisition.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "TENKU:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - PRIVATE PLACEMENTS", "menuCat": "Notes", "order": "10", "role": "http://tenxkeaneacquisition.com/role/PrivatePlacements", "shortName": "PRIVATE PLACEMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "TENKU:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - RELATED PARTIES", "menuCat": "Notes", "order": "11", "role": "http://tenxkeaneacquisition.com/role/RelatedParties", "shortName": "RELATED PARTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "12", "role": "http://tenxkeaneacquisition.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - SHAREHOLDERS\u2019 EQUITY (DEFICIT)", "menuCat": "Notes", "order": "13", "role": "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficit", "shortName": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "14", "role": "http://tenxkeaneacquisition.com/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "15", "role": "http://tenxkeaneacquisition.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "16", "role": "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "17", "role": "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "18", "role": "http://tenxkeaneacquisition.com/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-20", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)", "menuCat": "Details", "order": "19", "role": "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-10-172022-10-18", "decimals": "INF", "lang": null, "name": "TENKU:ConditionForFutureBusinessCombinationUseOfProceedsPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://tenxkeaneacquisition.com/role/BalanceSheets", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details)", "menuCat": "Details", "order": "20", "role": "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails", "shortName": "SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details)", "menuCat": "Details", "order": "21", "role": "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "shortName": "SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_OrdinarySharesSubjectToRedemptionMember", "decimals": "INF", "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "22", "role": "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-20", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SaleOfStockPricePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INITIAL PUBLIC OFFERING (Details Narrative)", "menuCat": "Details", "order": "23", "role": "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "shortName": "INITIAL PUBLIC OFFERING (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "TENKU:InitialPublicOfferingTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_IPOMember", "decimals": "INF", "lang": null, "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "span", "p", "TENKU:PrivatePlacementTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_PrivatePlacementMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - PRIVATE PLACEMENTS (Details Narrative)", "menuCat": "Details", "order": "24", "role": "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "shortName": "PRIVATE PLACEMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "TENKU:PrivatePlacementTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_PrivatePlacementMember", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockConversionBasis", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - RELATED PARTIES (Details Narrative)", "menuCat": "Details", "order": "25", "role": "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "shortName": "RELATED PARTIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:OtherGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-10-172022-10-18_custom_UnderwritersMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "26", "role": "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-10-172022-10-18_custom_UnderwritersMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SHAREHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)", "menuCat": "Details", "order": "27", "role": "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "shortName": "SHAREHOLDERS\u2019 EQUITY (DEFICIT) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_us-gaap_CommonStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)", "menuCat": "Details", "order": "28", "role": "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails", "shortName": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_us-gaap_FairValueInputsLevel1Member", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Statements of Operations", "menuCat": "Statements", "order": "4", "role": "http://tenxkeaneacquisition.com/role/StatementsOfOperations", "shortName": "Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31_us-gaap_RetainedEarningsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Changes In Shareholders' Equity (Deficit)", "menuCat": "Statements", "order": "5", "role": "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit", "shortName": "Statements of Changes In Shareholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31_us-gaap_RetainedEarningsMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-03-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "menuCat": "Notes", "order": "7", "role": "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern", "shortName": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "8", "role": "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "TENKU:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - INITIAL PUBLIC OFFERING", "menuCat": "Notes", "order": "9", "role": "http://tenxkeaneacquisition.com/role/InitialPublicOffering", "shortName": "INITIAL PUBLIC OFFERING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "TENKU:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 26, "tag": { "TENKU_AccruedFormationCostsCurrent": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued formation costs current.", "label": "Accrued formation costs" } } }, "localname": "AccruedFormationCostsCurrent", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "TENKU_AdjustmentsToAdditionalPaidInCapitalRemeasurementOfOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital remeasurement of ordinary shares subject to redemption.", "label": "Remeasurement of ordinary shares subject to redemption" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalRemeasurementOfOrdinarySharesSubjectToRedemption", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "TENKU_ChangesInDerivativeLiabilities": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in derivative liability.", "label": "Change in derivative liability" } } }, "localname": "ChangesInDerivativeLiabilities", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "TENKU_CommonStockSharesSubjectToMandatoryRedemptionNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock shares subject to mandatory redemption number of shares.", "label": "Common stock, shares subject to possible redemption" } } }, "localname": "CommonStockSharesSubjectToMandatoryRedemptionNumberOfShares", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "TENKU_ConditionForFutureBusinessCombinationThresholdPercentageOwnership": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition for future business combination threshold percentage ownership.", "label": "Condition for future business combination threshold percentage ownership" } } }, "localname": "ConditionForFutureBusinessCombinationThresholdPercentageOwnership", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "percentItemType" }, "TENKU_ConditionForFutureBusinessCombinationUseOfProceedsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Condition for future business combination use of proceeds percentage.", "label": "Condition for future business combination use of proceeds percentage" } } }, "localname": "ConditionForFutureBusinessCombinationUseOfProceedsPercentage", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "percentItemType" }, "TENKU_DeferredOfferingCostsIncludedInDueToRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs included in due to related party.", "label": "Deferred offering costs included in due to related party" } } }, "localname": "DeferredOfferingCostsIncludedInDueToRelatedParty", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "TENKU_DisclosureInitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering" } } }, "localname": "DisclosureInitialPublicOfferingAbstract", "nsuri": "http://tenxkeaneacquisition.com/20221231", "xbrltype": "stringItemType" }, "TENKU_DisclosurePrivatePlacementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placements" } } }, "localname": "DisclosurePrivatePlacementsAbstract", "nsuri": "http://tenxkeaneacquisition.com/20221231", "xbrltype": "stringItemType" }, "TENKU_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging Growth Company [Policy Text Block]", "label": "Emerging Growth Company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "TENKU_IncreaseDecreaseFormationAndOrganizationCostsPaidByRelatedParties": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease formation and organization costs paid by related parties.", "label": "Formation and organization costs paid by related parties" } } }, "localname": "IncreaseDecreaseFormationAndOrganizationCostsPaidByRelatedParties", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "TENKU_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial Public Offering [Text Block]", "label": "INITIAL PUBLIC OFFERING" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "TENKU_InterestIncomeOnInvestmentsHeldInTrust": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest income on investments held in trust account.", "label": "Interest income on investments held in trust account", "negatedLabel": "Interest income on investments held in trust account" } } }, "localname": "InterestIncomeOnInvestmentsHeldInTrust", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows", "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "TENKU_MaximumAllowedDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Maximum allowed dissolution expenses.", "label": "Maximum allowed dissolution expenses" } } }, "localname": "MaximumAllowedDissolutionExpenses", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "TENKU_NetTangibleAssetsUponRedemptionOfBusinessCombinations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net tangible assets upon redemption of business combinations.", "label": "Net tangible assets upon redemption of business combinations" } } }, "localname": "NetTangibleAssetsUponRedemptionOfBusinessCombinations", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "TENKU_OfferingCostsAllocatedOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Offering costs allocated ordinary shares subject to redemption.", "label": "Offering costs allocated ordinary shares subject to redemption" } } }, "localname": "OfferingCostsAllocatedOrdinarySharesSubjectToRedemption", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "TENKU_OrdinarySharesNotSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary Shares Not Subject To Redemption [Member]", "label": "Ordinary Shares Not Subject To Redemption [Member]" } } }, "localname": "OrdinarySharesNotSubjectToRedemptionMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails" ], "xbrltype": "domainItemType" }, "TENKU_OrdinarySharesParValue0.0001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary Shares Par Value 0.0001 Per Share [Member]", "label": "Ordinary Shares Par Value 0.0001 Per Share [Member]" } } }, "localname": "OrdinarySharesParValue0.0001PerShareMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "TENKU_OrdinarySharesSubjectToRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ordinary Shares Subject To Redemption [Member]", "label": "Ordinary Shares Subject To Redemption [Member]" } } }, "localname": "OrdinarySharesSubjectToRedemptionMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_OtherOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "TENKU_PaymentsForNonCashUnderwritingExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for non cash underwriting expense.", "label": "Non-cash underwriting fees" } } }, "localname": "PaymentsForNonCashUnderwritingExpense", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "TENKU_PaymentsForOtherFees": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for other fees.", "label": "PaymentsForOtherFees", "negatedLabel": "Other fees" } } }, "localname": "PaymentsForOtherFees", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "TENKU_PaymentsForUnderwritingFees": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for underwriting fees.", "label": "PaymentsForUnderwritingFees", "negatedLabel": "Underwriting fee" } } }, "localname": "PaymentsForUnderwritingFees", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "TENKU_PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage obligation to redeem public shares if entity does not complete business combination.", "label": "Percentage obligation to redeem public shares if entity does not complete business combination" } } }, "localname": "PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "percentItemType" }, "TENKU_PercentageOfIssuedAndOutstandingShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of issued and outstanding shares.", "label": "Percentage of issued and outstanding shares" } } }, "localname": "PercentageOfIssuedAndOutstandingShares", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "percentItemType" }, "TENKU_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Private Placement [Text Block]", "label": "PRIVATE PLACEMENTS" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/PrivatePlacements" ], "xbrltype": "textBlockItemType" }, "TENKU_ProceedsAllocatedToPublicRights": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds allocated to public rights.", "label": "Proceeds allocated to public rights" } } }, "localname": "ProceedsAllocatedToPublicRights", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "TENKU_PublicShareholdersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Shareholders [Member]", "label": "Public Shareholders [Member]" } } }, "localname": "PublicShareholdersMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_RedemptionLimitPercentageWithoutPriorWrittenConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption limit percentage without prior written consent.", "label": "Redemption limit percentage without prior written consent" } } }, "localname": "RedemptionLimitPercentageWithoutPriorWrittenConsent", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "percentItemType" }, "TENKU_RemeasurementOfOrdinarySharesSubjectToRedemption": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remeasurement of ordinary shares subject to redemption.", "label": "RemeasurementOfOrdinarySharesSubjectToRedemption", "verboseLabel": "Remeasurement of ordinary shares subject to redemption" } } }, "localname": "RemeasurementOfOrdinarySharesSubjectToRedemption", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "TENKU_RightsEachRightEntitlingHolderToReceiveTwotenthsOfOneOrdinaryShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rights Each Right Entitling Holder To Receive Twotenths Of One Ordinary Share [Member]", "label": "Rights Each Right Entitling Holder To Receive Twotenths Of One Ordinary Share [Member]" } } }, "localname": "RightsEachRightEntitlingHolderToReceiveTwotenthsOfOneOrdinaryShareMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "TENKU_ShareholderReceivable": { "auth_ref": [], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shareholder receivable.", "label": "Shareholder receivable" } } }, "localname": "ShareholderReceivable", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "TENKU_ShareholderReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shareholder Receivable [Member]", "label": "Shareholder Receivable [Member]" } } }, "localname": "ShareholderReceivableMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "TENKU_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor [Member]", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_StockIssuedDuringPeriodSharesFairValueOfPublicRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares fair value of public rights.", "label": "Fair value of public rights, shares" } } }, "localname": "StockIssuedDuringPeriodSharesFairValueOfPublicRights", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "TENKU_StockIssuedDuringPeriodSharesFairValueOfUnderwriterShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares fair value of underwriter shares.", "label": "Fair value of underwriter shares, shares" } } }, "localname": "StockIssuedDuringPeriodSharesFairValueOfUnderwriterShares", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "TENKU_StockIssuedDuringPeriodValueFairValueOfPublicRights": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value fair value of public rights.", "label": "Fair value of public rights" } } }, "localname": "StockIssuedDuringPeriodValueFairValueOfPublicRights", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "TENKU_StockIssuedDuringPeriodValueFairValueOfUnderwriterShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value fair value of underwriter shares.", "label": "Fair value of underwriter shares" } } }, "localname": "StockIssuedDuringPeriodValueFairValueOfUnderwriterShares", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "TENKU_TemporaryEquityAccruedInterestInTrust": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary equity accrued interest in trust.", "label": "TemporaryEquityAccruedInterestInTrust", "verboseLabel": "Remeasurement of ordinary shares subject to redemption" } } }, "localname": "TemporaryEquityAccruedInterestInTrust", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "TENKU_ToBePaidLaterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "To Be Paid Later [Member]", "label": "To Be Paid Later [Member]" } } }, "localname": "ToBePaidLaterMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_UnderwriterMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriter [Member]", "label": "Underwriter [Member]" } } }, "localname": "UnderwriterMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_UnderwritingCommitmentsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting commitments per share.", "label": "Aggregate underwriting discount" } } }, "localname": "UnderwritingCommitmentsPerShare", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "TENKU_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightEntitlingHolderToReceiveTwotenthsOfOrdinaryShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Units Each Consisting Of One Ordinary Share 0.0001 Par Value [Member]", "label": "Units Each Consisting Of One Ordinary Share 0.0001 Par Value [Member]" } } }, "localname": "UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightEntitlingHolderToReceiveTwotenthsOfOrdinaryShareMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "domainItemType" }, "TENKU_UnsecuredPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unsecured Promissory Note [Member]", "label": "Unsecured Promissory Note [Member]" } } }, "localname": "UnsecuredPromissoryNoteMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_WorkingCapitalLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working Capital Loan [Member]", "label": "Working Capital Loan [Member]" } } }, "localname": "WorkingCapitalLoanMember", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "TENKU_WorkingCapitalLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital loans.", "label": "Working capital loans" } } }, "localname": "WorkingCapitalLoans", "nsuri": "http://tenxkeaneacquisition.com/20221231", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r327", "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r327", "r329", "r330" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r327", "r329", "r330" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r327", "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r330" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r327", "r329", "r330" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r329" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r320" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_MaximumMember": { "auth_ref": [ "r144", "r145", "r146", "r147", "r198", "r272", "r288", "r297", "r298", "r309", "r313", "r315", "r354", "r362", "r363", "r364", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r144", "r145", "r146", "r147", "r198", "r272", "r288", "r297", "r298", "r309", "r313", "r315", "r354", "r362", "r363", "r364", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r144", "r145", "r146", "r147", "r190", "r198", "r221", "r222", "r223", "r271", "r272", "r288", "r297", "r298", "r309", "r313", "r315", "r350", "r354", "r363", "r364", "r365", "r366", "r367" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r144", "r145", "r146", "r147", "r190", "r198", "r221", "r222", "r223", "r271", "r272", "r288", "r297", "r298", "r309", "r313", "r315", "r350", "r354", "r363", "r364", "r365", "r366", "r367" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r347", "r358" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r92", "r93", "r252", "r253", "r254", "r255", "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r7", "r314" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r225", "r226", "r227", "r342", "r343", "r344", "r356" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "auth_ref": [ "r46", "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "negatedLabel": "Issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r63", "r71", "r83", "r99", "r132", "r134", "r136", "r138", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r157", "r158", "r239", "r241", "r251", "r314", "r352", "r353", "r360" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r79", "r88", "r99", "r138", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r157", "r158", "r239", "r241", "r251", "r314", "r352", "r353", "r360" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r294", "r295", "r314", "r337" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r25", "r30", "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash at end of period", "periodStartLabel": "Cash at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r25", "r58" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r337" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r84", "r85", "r86", "r99", "r117", "r118", "r120", "r122", "r125", "r126", "r138", "r148", "r151", "r152", "r153", "r157", "r158", "r175", "r176", "r178", "r182", "r188", "r251", "r299", "r336", "r338", "r345" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r15", "r67", "r74" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r40", "r142", "r143", "r296", "r351" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Ordinary share conversion basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r342", "r343", "r356" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Ordinary shares, par value", "verboseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Ordinary shares, shares authorized", "verboseLabel": "Common stock, stock authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Ordinary shares, shares issued", "verboseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r6", "r46" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Ordinary shares, shares outstanding", "verboseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r6", "r314" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Ordinary shares, $0.0001 par value; 150,000,000 shares authorized; 2,416,000 shares issued and outstanding (excluding 6,600,000 shares subject to possible redemption)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r69", "r129" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r2", "r3", "r4", "r64", "r65", "r70", "r101", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r258", "r304", "r305", "r306", "r307", "r308", "r339" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r59", "r60", "r159", "r258", "r305", "r306" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r14", "r101", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r258", "r304", "r305", "r306", "r307", "r308", "r339" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Offering Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r349" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r50", "r51", "r52", "r53", "r54", "r100" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r12", "r150", "r151", "r152", "r156", "r157", "r158", "r263", "r341" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to related party", "verboseLabel": "Due to related parties, current" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r95", "r107", "r108", "r109", "r110", "r111", "r115", "r117", "r120", "r121", "r122", "r123", "r245", "r246", "r286", "r287", "r302" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted net income (loss) per ordinary share for ordinary shares not subject to redemption", "verboseLabel": "Basic and diluted net income per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r95", "r107", "r108", "r109", "r110", "r111", "r117", "r120", "r121", "r122", "r123", "r245", "r246", "r286", "r287", "r302" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted net income (loss) per ordinary share for ordinary shares subject to redemption" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r34", "r35" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net income (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r46", "r77", "r92", "r93", "r94", "r102", "r103", "r104", "r106", "r112", "r114", "r124", "r139", "r189", "r225", "r226", "r227", "r237", "r238", "r244", "r252", "r253", "r254", "r255", "r256", "r257", "r259", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r247", "r248", "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r55" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "SCHEDULE OF ASSETS AND LIABILITIES MEASURED AT FAIR VALUE" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r167", "r191", "r192", "r193", "r194", "r195", "r196", "r248", "r268", "r269", "r270", "r305", "r306", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r167", "r191", "r196", "r248", "r268", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r167", "r191", "r192", "r193", "r194", "r195", "r196", "r268", "r269", "r270", "r305", "r306", "r310", "r311", "r312" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r56", "r57" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r19" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative costs" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r91", "r229", "r230", "r233", "r234", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r28" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r301" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "verboseLabel": "Deferred offering costs" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r28" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r11", "r66", "r73", "r314", "r340", "r348", "r357" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders\u2019 Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r13", "r80", "r99", "r138", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r157", "r158", "r240", "r241", "r242", "r251", "r314", "r352", "r360", "r361" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermInvestments": { "auth_ref": [ "r81" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).", "label": "Investments held in trust account" } } }, "localname": "LongTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale.", "label": "Marketable securities held in the Trust Account" } } }, "localname": "MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r96" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r25", "r27", "r29" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r17", "r29", "r68", "r75", "r78", "r89", "r90", "r94", "r99", "r105", "r107", "r108", "r109", "r110", "r113", "r114", "r119", "r132", "r133", "r135", "r137", "r138", "r148", "r149", "r151", "r152", "r153", "r154", "r155", "r157", "r158", "r246", "r251", "r303", "r352" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit", "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r20" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Income" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r132", "r133", "r135", "r137", "r303" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r49" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS AND GOING CONCERN" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcern" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r19" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Administrative service expenses" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Cash underwriting fees" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r24" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Transaction costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherInvestments": { "auth_ref": [ "r21" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investments classified as other.", "label": "Payments to Acquire Other Investments", "negatedLabel": "Cash deposited into trust account" } } }, "localname": "PaymentsToAcquireOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r5", "r175" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock, par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r5", "r175" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r5", "r314" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r87", "r140", "r141", "r300" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from initial public offering, costs" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r22" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Sale of ordinary shares" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r22" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Net proceeds from sale of private placement ordinary shares", "verboseLabel": "Proceeds from private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherEquity": { "auth_ref": [ "r22" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the issuance of equity classified as other.", "label": "Proceeds from issuance ordinary shares to sponsor" } } }, "localname": "ProceedsFromOtherEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r197", "r262", "r263" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r76", "r262", "r263", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party." } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r197", "r262", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r359" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r260", "r261", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTIES" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r23" ], "calculation": { "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of related party debt", "negatedLabel": "Repayment of sponsor note" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r8", "r47", "r72", "r292", "r293", "r314" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r77", "r102", "r103", "r104", "r106", "r112", "r114", "r139", "r225", "r226", "r227", "r237", "r238", "r244", "r289", "r291" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.", "label": "Exchange amounts transaction" } } }, "localname": "SaleOfStockConsiderationReceivedPerTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of stock shares issued in transaction", "verboseLabel": "Ordinary shares exchanged in consideration for issuance" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Price per share", "verboseLabel": "Sale of stock price per share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "SCHEDULE OF BASIC AND DILUTED NET INCOME (LOSS) PER ORDINARY SHARE" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r61", "r62" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Ordinary shares forfeiture", "verboseLabel": "Common stock shares not subject to forfeiture" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r199", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Outstanding percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.", "label": "Ordinary Shares Subject to Possible Redemption" } } }, "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionDisclosureTextBlock": { "auth_ref": [ "r41", "r42", "r44" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature and terms of the financial instruments and the rights and obligations embodied in those instruments, information about settlement alternatives, if any, in the contract and identification of the entity that controls the settlement alternatives including: a. The amount that would be paid, or the number of shares that would be issued and their fair value, determined under the conditions specified in the contract if the settlement were to occur at the reporting date b. How changes in the fair value of the issuer's equity shares would affect those settlement amounts (for example, \"the issuer is obligated to issue an additional x shares or pay an additional y dollars in cash for each $1 decrease in the fair value of one share\") c. The maximum amount that the issuer could be required to pay to redeem the instrument by physical settlement, if applicable d. The maximum number of shares that could be required to be issued, if applicable e. That a contract does not limit the amount that the issuer could be required to pay or the number of shares that the issuer could be required to issue, if applicable f. For a forward contract or an option indexed to the issuer's equity shares, the forward price or option strike price, the number of issuer's shares to which the contract is indexed, and the settlement date or dates of the contract, as applicable. g. The components of the liability that would otherwise be related to shareholders' interest and other comprehensive income (if any) subject to the redemption feature (for example, par value and other paid in amounts of mandatorily redeemable instruments are disclosed separately from the amount of retained earnings or accumulated deficit).", "label": "SCHEDULE OF SHARES SUBJECT TO POSSIBLE REDEMPTION" } } }, "localname": "SharesSubjectToMandatoryRedemptionDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmount": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount that would be paid, determined under the conditions specified in the contract, if the holder of the share has the right to redeem the shares.", "label": "Gross proceeds" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r33", "r97" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SponsorFees": { "auth_ref": [ "r18" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees paid to advisors who provide certain management support and administrative oversight services including the organization and sale of stock, investment funds, limited partnerships and mutual funds.", "label": "Sponsor fees" } } }, "localname": "SponsorFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r84", "r85", "r86", "r99", "r117", "r118", "r120", "r122", "r125", "r126", "r138", "r148", "r151", "r152", "r153", "r157", "r158", "r175", "r176", "r178", "r182", "r188", "r251", "r299", "r336", "r338", "r345" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r16", "r46", "r77", "r92", "r93", "r94", "r102", "r103", "r104", "r106", "r112", "r114", "r124", "r139", "r189", "r225", "r226", "r227", "r237", "r238", "r244", "r252", "r253", "r254", "r255", "r256", "r257", "r259", "r289", "r290", "r291" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r102", "r103", "r104", "r124", "r273" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/Cover", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r5", "r6", "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of ordinary shares to Sponsor, shares", "terseLabel": "Private sale of private placement units", "verboseLabel": "Stock issued during period shares new issues" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Private placement rights proceeds, shares" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r5", "r6", "r46", "r47", "r207" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock issued during period shares option exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r5", "r6", "r46", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of ordinary shares to Sponsor" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Private placement rights proceeds" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r5", "r6", "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Common stock, authorized but unissued" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r5", "r6", "r46", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock repurchased during period, shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r5", "r6", "r46", "r47" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Payment for founder shares" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r6", "r9", "r10", "r39", "r314", "r340", "r348", "r357" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Shareholders\u2019 Equity (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets", "http://tenxkeaneacquisition.com/role/StatementsOfChangesInShareholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r48", "r98", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r189", "r243" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "SHAREHOLDERS\u2019 EQUITY (DEFICIT)" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/DescriptionOfOrganizationAndBusinessOperationsAndGoingConcernDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/RelatedPartiesDetailsNarrative", "http://tenxkeaneacquisition.com/role/ShareholdersEquityDeficitDetailsNarrative", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://tenxkeaneacquisition.com/role/InitialPublicOfferingDetailsNarrative", "http://tenxkeaneacquisition.com/role/PrivatePlacementsDetailsNarrative", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r148", "r151", "r152", "r153", "r157", "r158" ], "calculation": { "http://tenxkeaneacquisition.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Ordinary shares subject to possible redemption (6,600,000 shares at $10.27 per share)", "totalLabel": "Ordinary shares subject to possible redemption", "verboseLabel": "Ordinary shares subject to possible redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheets", "http://tenxkeaneacquisition.com/role/ScheduleOfSharesSubjectToPossibleRedemptionDetails", "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r1", "r45" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r228", "r232" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Amounts accrued for interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r36", "r37", "r38", "r127", "r128", "r130", "r131" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r116", "r122" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average ordinary shares outstanding, basic and diluted for ordinary shares subject to redemption" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r115", "r122" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average ordinary shares outstanding, basic and diluted for ordinary shares not subject to redemption", "verboseLabel": "Basic and diluted weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://tenxkeaneacquisition.com/role/ScheduleOfBasicAndDilutedNetIncomeLossPerOrdinaryShareDetails", "http://tenxkeaneacquisition.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r316": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r317": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r318": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r319": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r321": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r322": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r323": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r324": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r325": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r326": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r327": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r328": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r329": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r33": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r331": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r332": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r333": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r334": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r335": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r351": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=118255708&loc=SL5909891-110878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22026-110879", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(12))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 47 0001493152-23-012545-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-012545-xbrl.zip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end